| Code | Abstract | Authors | Category |
| P1 | PITUITARY-ADRENAL AXIS IN MALE RATS AFTER EXPOSURE TO HIGH AMBIENT TEMPERATURE | F Percinic-Popovska, V Ajdzanovic, S Trifunovic, M Jordanova, V Ilieski, L Pendovski, V Milosevic | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P2 | RELATIVAL ADRENAL FAILURE IN TRAUMA PATIENT – THERAPY APPROACH | EDUARD CIRCO, MARIAN BECIU, RAZVAN CIRCO | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P3 | MicroRNAs as endogenous modulators of Glucocorticoid Receptor expression in the adrenal gland after ACTH stimulation test | A Hill, O Issler, A Spyroglou, S Haramati, A Chen, F Beuschlein | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P4 | EFFECTS AND KINETICS OF MITOTANE IN IN VITRO AND IN VIVO MODELS OF ADRENOCORTICAL CARCINOMA | M Luconi, G Poli, M Mangoni, P Pezzati, M Francalanci, S Gelmini, L Canu, G Cantini, M Serio, M Mannelli | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P5 | The utility of FDG-PET CT in differentiating malignant from benign adrenal lesions | Basak Oguz, Sayid Shafi Zuhur, Ozcan Karaman, Selvinaz Velet, Yuksel Altuntas | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P6 | CT Imaging in Patients with Adrenal Incidentaloma | J Brunova, J Bruna | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P7 | Self-management in patients with adrenal insufficiency | J.P. van Eck, R.J. Gobbens, J. Beukers, W. Geilvoet, A.J. van der Lely, S.J.C.M.M Neggers | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P8 | Validation of the disease-specific quality of life questionnaire AddiQoL in European Addison patients | M Øksnes, K Løvås | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P9 | Diagnostic value of urinary steroid profiling for detecting adrenocortical carcinoma | T.M.A. Kerkhofs, M.N. Kerstens, I.P. Kema, I.G.C. Hermsen, H.R. Haak | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P10 | Surgery in Adrenocortical Carcinoma; Importance of National Cooperation and Centralized Surgery. | IGC Hermsen, TMA Kerkhofs, G Den Butter, J Kievit, C Eijck, E Nieveen van Dijkum, HR Haak | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P11 | Arthritis after Removal of Adrenal Adenoma in Cushing's Syndrome | Maria-Christina Ungureanu, Adriana Cernohuz, Carmen Gorduza, Viorel Scripcariu, Carmen Vulpoi, Cristina Preda | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P12 | Influence of drospirenone on renin-angiotensin-aldosterone system evaluation | L. Vroonen, E. Cavalier, L. Vranken, H. Valdes-Socin, P. Petrossians, A. Beckers | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P13 | Redefinition of age and sex specific reference intervals of eight serum steroids by liquid chromatography - tandem mass spectrometry (LC-MS/MS) | F Fanelli, I Belluomo, VD Di Lallo, M Baccini, E Casadio, D Ibarra Gasparini, A Gambineri, R Pasquali, Uberto Pagotto | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P14 | Autosomal recessive pseudohypoaldosteronism – A rare cause of life-threatening electrolyte imbalance | K Tharian, J T Warner, J Gregory | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P15 | Interstitial cortisol levels obtained by adipose tissue microdialysis in mechanically ventilated septic patients: correlations with total and free serum cortisol | I Ilias, I Dimopoulou, N Nikitas, M Tzanela, M Theodorakopoulou, D. A. Vassiliadi, P Kopteridis, N Maniatis, Argyris Diamantakis, Stylianos Orfanos, Ilias Perogamvros, U. Ungerstedt, B.G. Keevil, Stylianos Tsagarakis | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P16 | Potential role of mast cells in the physiopathology of aldosterone-producing adenoma. | Céline Duparc, Lucile Moreau, Véronique Perraudin, Françoise Gobet, Tchao Meatchi, Pierre-François Plouin, Maria-Christina Zennaro, Estelle Louiset, Hervé Lefebvre | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P18 | Bilateral primary adrenocortical carcinoma developing severe muscle weakness | N Kumagai, M Shimodaira, K Tsuzawa, E Sorimachi, M Kametaka, K Honda | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P19 | Polymorphisms of the HSD11B1 gene as phenotype modifiers in women with hypercortisolism | K Feldman, A Szappanos, I Liko, B Acs, M Toth, A Patocs, K Racz | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P20 | Clinical presentation of Cushing’s syndrome in a large series from the European Registry on Cushing’s Syndrome (ERCUSYN) | Elena Valassi, Alicia Santos, Maria Yaneva, Miklos Toth, Christian Strasburger, Phillippe Chanson, John Wass, Olivier Chabre, Marija Pfeifer, Richard Feelders, Stylianos Tsagarakis, Peter Trainer, Holger Franz, Kathrin Zopf, Sabina Zacharieva, Steven Lamberts, Susan Webb | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P21 | MORTALITY AND MORBIDITY IN CUSHING’S SYNDROME: A SINGLE CENTRE EXPERIENCE. | P Vitale, A Cozzolino, M De Leo, C Simeoli, M Galdiero, LFS Grasso, A Colao, R Pivonello | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P22 | CARDIAC STRUCTURE AND FUNCTION IN PATIENTS WITH ADRENAL INCIDENTALOMA WITH AND WITHOUT SUBCLINICAL CUSHING’S SYNDROME. | M De Leo, M Galderisi, A Cozzolino, C Simeoli, P Vitale, R Raia, A Colao, R Pivonello | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P23 | Multicenter Study on the Prevalence of Sexual Symptoms in Men affected by Addison Disease | A. Granata, V. Pugni, G. Arnaldi, A. Guidi, D. Santi, G. Balercia, C. Carani | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P24 | Hormones failing the heart | M Pierides, J Cullen, S Al-Hamali, K Patel, B O'Malley | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P25 | Cushing’s syndrome in pregnancy due to LH/hCG receptor positive adrenocortical carcinoma: case report. | S Tigas, K Zikopoulos, Z Lei, C Rao, A Tsatsoulis | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P26 | PREDICTIVE VALUE OF ACUTE CORTISOL RESPONSE TO CABERGOLINE ADMINISTRATION ON THE RESPONSIVENESS OF CORTISOL SECRETION TO SHORT AND LONG TERM TREATMENT WITH CABERGOLINE | P Vitale, A Cozzolino, M De Leo, C Simeoli, M Galdiero, G Lombardi, A Colao, R Pivonello | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P27 | DO MITOTANE LEVELS IMPACT ON THE OUTCOME OF PATIENTS TREATED ADJUVANTLY FOLLOWING RADICAL RESECTION OF ADRENOCORTICAL CANCER (ACC)? | A ARDITO, A AL GHUZIAN, M FASSNACHT, F DAFFARA, S LEBOULLEUX, S WORTMANN, B ZAGGIA, S DE FRANCIA, Marco VOLANTE, Luigi GONZAGA, Alfredo BERRUTI, Bruno ALLOLIO, Eric BAUDIN, Massimo TERZOLO | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P28 | IMPACT OF LONG-TERM CABERGOLINE TREATMENT ON CLINICAL, METABOLIC AND HORMONAL FEATURES IN PATIENTS WITH CUSHING’S SYNDROME | A Cozzolino, P Vitale, M De Leo, C Simeoli, LFS Grasso, G Lombardi, A Colao, R Pivonello | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P29 | TP53 and Adrenocortical Cancer - analysis of germline mutations and polymorphic changes in 140 patients | Leonie Herrmann, Britta Heinze, Martin Fassnacht, Holger Willenberg, Marcus Quinkler, Nicole Reisch, Bruno Allolio, Stefanie Hahner | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P30 | Is plasma mitotane level >30mg/L a serious adverse event in patients with adrenocortical carcinoma (ACC)? : a retrospective analysis of the French COMETE network. | SMD MAUCLERE-DENOST, AT TABARIN, DD DRUI, LC CHAILLOUS, SS SALENAVE, SL LEBOULLEUX, OC CHABRE, CDC DO-CAO, HD DUBOURG, MLC CUVELIER, JY YOUNG, EB BAUDIN | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P31 | 18-Oxocortisol Measurement in Adrenal Vein Sampling As a Biomarker for Subclassifying Primary Aldosteronism | F Satoh, Y Nakamura, R Morimoto, M Kudo, K Takase, H Sasano, S Ito | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P32 | MISSION STUDY: AN INTERNATIONAL OBSERVATIONAL STUDY ON THE MORTALITY IN CUSHING’S SYNDROME. | R Pivonello, G Melnichenko, S Zacharieva, F Gu, B Oscar, NS Shah, R Gaillard, A Colao | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P33 | RESPONSE OF HUMAN ADRENOCORTICAL CARCINOMA CELL LINES TO CYTOSTATIC DRUGS AND MITOTANE AND THE ROLE OF THE MULTIDRUG RESISTANCE PUMP MDR1 | P.M. van Koetsveld, F. Dogan, M.B. Misier, R.A. Feelders, W.W. de Herder, L.J. Hofland | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P34 | Norwegian Patients with Congenital Adrenal Hyperplasia have a high frequency of Adrenal Myelolipomas and Adrenal Hypoplasia, and Testicular Adrenal Rest Tumours was only detected in men with the Saltwasting Form. | IN Nermoen, JR Rørvik, SHH Holmedal, DLH Hykkerud, KJ Fougner, JS Svartberg, ESH Husebye, KL Løvås | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P35 | PRESENCE OF LIVER X RECEPTORS alfa (LXRalfa) AND beta (LXRbeta) IN CORTISOL-SECRETING ADRENAL ADENOMAS | G Bellastella, D Visconti, G Conzo, V Rossi, V Palumbo, A De Bellis, A Bellastella, AA Sinisi | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P36 | Radiosurgery with application of protone beam in patients with Cushing's disease: a hormonal monitoring of the long-term results | E Marova, N Goncharov, G Kolesnikova, S Arapova, M Zhimirikina, O Manchenko | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P37 | Thoracic and GastroEnteroPancreatic (GEP) Neuroendocrine Tumors (NETs) and the Ectopic Adrenocorticotropin (ACTH) Syndrome (EAS). | K Kamp, A Alwani, RA Feelders, WW de Herder | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P38 | The role of Insulin tolerance test (ITT) and ACTH/Cortisol ratio in chronic fatigue patients. | F Coucke, T Hertoghe, G Rindsig, L Coucke, H Lammens | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P39 | Quality of life in patients in long-term remission of Cushing’s syndrome is impaired, regardless of etiology, treatment strategy or remaining hormonal deficiencies. | M Wagenmakers, R Netea-Maier, T Dekkers, M den Heijer, A Hermus | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P40 | Sunitinib in refractory adrenocortical carcinoma: results of a phase II trial | M Fassnacht, M Kroiss, S Hahner, C Strasburger, B Allolio, M Quinkler | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P41 | ADRENAL INSUFFICIENCY - etiopathogeny and diagnostic aspects | Corina Crista, Corina Laura Niederl | 1. Adrenal cortex (to include Cushing’s and adrenal carcinoma) |
| P42 | EVALUATION OF THE EFFECT OF L-THYROXIN THERAPY ON ENDOTHELIAL FUNCTIONS IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM | FATMA ALIBAZ ONER, SELEN YURDAKUL, ENDER ONER, AYSE KUBAT UZUM, MECDI ERGUNEY | 10. Endocrine Disruptors |
| P43 | EVALUATION OF THE INCIDENCE OF DISORDERS GLYCOREGULATION IN SOME DISEASES ENDOCRINE | I. Bistriceanu, M.E. Preda, M. Bistriceanu, L. Putinelu, S Bondari, A Covei, A Turcu, A Voican | 10. Endocrine Disruptors |
| P44 | REAL-IDIOPATHIC PRECOCIOUS PUBERTY: THERAPEUTIC APPROACH | I. Bistriceanu, M.E. Preda, M. Bistriceanu, L. Putinelu, S Bondari, A Covei, A Turcu, D. Bondari | 10. Endocrine Disruptors |
| P45 | Haematological and reproductive toxicity of nicotine and protective role of green tea extract in male rats. | MOSBAH Rachid, HAROUN Nacera, BOULAKOUD Mohamed Salah, YOUSEF Mokhtar Ibrahim | 10. Endocrine Disruptors |
| P46 | Bone remodeling parameters and bone mass in patients with schizophrenia treated with long-acting injectable risperidone | M Doknic, N Maric Bojovic, S Pekic, D Britvic, A Damjanovic, M Jasovic Gasic, V Popovic | 10. Endocrine Disruptors |
| P47 | PROGNOSTIC FACTORS OF NON-ALCOHOLIC STEATOHEPATITIS ASSOCIATED WITH OBESITY | M. Popescu, D. Neagoe, A.I. Popescu, I. Bistriceanu, M. Dinca, M. Bistriceanu, M.E. Preda | 10. Endocrine Disruptors |
| P48 | The role of progestins in the interplay of estradiol and genistein - Influences on the steroid hormone receptor expression patterns in distinct uterine compartments | F Möller, P Hönschied, O Zierau, P Diel, G Vollmer | 10. Endocrine Disruptors |
| P49 | Serum procalcitonin measurement as a marker of sepsis | E Puca, E Puca, P Pipero, A Pilaca, Z Ylli, A Ylli, DH Kraja | 10. Endocrine Disruptors |
| P50 | Parathyroid adenoma screening efficacies of different imaging tools and factors affecting the success rates | E Çakal, E Cakir, A Dilli, N Colak, I Ozturk, M Ozbek, M Kilic, T Dellibasi | 10. Endocrine Disruptors |
| P51 | In vitro testing for goitrogenic potential of glucosinolate extracts | K Renko, I Mewis, M Schreiner, L Schomburg, J Köhrle | 10. Endocrine Disruptors |
| P52 | Phytoestrogen Genistein Causes Downregulation of Oestrogen Receptor α In Uterus of Female Sprague Dawley Rats | Siti Rosmani Md Zin, Normadiah M. Kassim, Siti Zawiah Omar | 10. Endocrine Disruptors |
| P53 | INSULINOMA IN CRETE: A RARE TUMOR? | V. Daraki, K. Stamou, G. Kalikakis, F. Spyrou, A.M. Golac, E. Karipidou, E. Mamalaki, S. Papavasiliou | 11. Endocrine tumours and neoplasia (to include NETs) |
| P54 | Frequency, localisation of unusual metastases of medullary thyroid cancer and impact on survival: an observational study in 102 patients | L Crinière, P Pierre, E Baudin, S Guyétant, P Lecomte | 11. Endocrine tumours and neoplasia (to include NETs) |
| P55 | Diagnosis of post-surgical recurrence in patients with malignant insulinoma | A Buffet, D Vezzosi, J-C Maiza, S Grunenwald, A Bennet, Ph Otal, N Carrere, Ph Caron | 11. Endocrine tumours and neoplasia (to include NETs) |
| P56 | The T-box transcription factor TBX1, the candidate gene of 22q11.2 microdeletion/DiGeorge syndrome, is involved in human parathyroid tumorigenesis. | C Verdelli, A Donnangelo, V Vaira, M Meregalli, M Belicchi, V Guarneri, A Scillitani, L Vicentini, Filomena Cetani, Stefano Ferrero, Marcello Frigerio, Elena Costa, Bruno Ambrosi, Yvan Torrente, Silvano Bosari, Anna Spada, Sabrina Corbetta | 11. Endocrine tumours and neoplasia (to include NETs) |
| P57 | CLINICOPATHOLOGICAL CHARACTERISTICS OF PANCREATIC NEUROENDOCRINE TUMORS AT DIAGNOSIS | M Argente Pla, MI Del Olmo García, M Rubio Almanza, A Moya Herráiz, A Segura Huerta, A Ramos Prol, R Cámara Gómez, JF Merino Torres | 11. Endocrine tumours and neoplasia (to include NETs) |
| P58 | A large adrenal tumour as a phenotypic manifestation of the Birt-Hogg-Dube syndrome | A Juszczak, D Halliday, R Mihai, A Ali | 11. Endocrine tumours and neoplasia (to include NETs) |
| P59 | METABOLIC SYNDROME RELATED TO ADRENAL INCIDENTALOMA – OBSERVATIONAL STUDY | EDUARD CIRCO, MARIAN BECIU, RAZVAN CIRCO | 11. Endocrine tumours and neoplasia (to include NETs) |
| P60 | Development and characterisation of patient-individual tumor models for endocrine tumors | C Hantel, F Scheller, A Ozimek, C Chiapponi, T Mussack, F Beuschlein | 11. Endocrine tumours and neoplasia (to include NETs) |
| P61 | Liposome based strategies for the treatment of adrenocortical carcinoma | C Hantel, F Lewrick, M Reincke, R Süss, F Beuschlein | 11. Endocrine tumours and neoplasia (to include NETs) |
| P62 | Injection Systems for Long-Acting Somatostatin Analogs : A Comparative Assessment of Preparation Times and Nurses' Perceptions | DT Adelman, A Burgess, PR Davies | 11. Endocrine tumours and neoplasia (to include NETs) |
| P63 | The influence of different ACTH assays on the ACTH concentrations of patients with small cell lung cancer | J.A.P. Bons, A.C. Dingemans, P.P.C.A. Menheere | 11. Endocrine tumours and neoplasia (to include NETs) |
| P64 | Primary hyperparathyroidism in MEN1 patients: preferred surgical procedure and relation with genotype | CRC Pieterman, LT van Hulsteijn, M den Heijer, RB van der Luijt, ARMM Hermus, MR Vriens, GD Valk | 11. Endocrine tumours and neoplasia (to include NETs) |
| P65 | Significance of BRAF expression in nodular thyroid disease: prognostic and therapeutic implications | Ioana Golu, Adriana Neghina, Marioara Cornianu, Daniela Amzar, Melania Balas, Dana David, Mihaela Vlad | 11. Endocrine tumours and neoplasia (to include NETs) |
| P66 | Metabolic endocrine tumour activity is reflected by total 18F-DOPA PET tumor uptake in patients with a carcinoid tumour | H-B Fiebrich, J.R. de Jong, I.P. Kema, K.P. Koopmans, W.J. Sluiter, R.A.J.O. Dierckx, A.M.E. Walenkamp, A.H. Brouwers, E.G.E. de Vries, T.P. Links | 11. Endocrine tumours and neoplasia (to include NETs) |
| P67 | Ectopic mediastinal parathyroid adenoma: a case report | C Lazureanu, M Cornianu, R Cornea, M Vlad, O Burlacu, A Nicodin, E Lazar | 11. Endocrine tumours and neoplasia (to include NETs) |
| P68 | Significant prognostic survival factors in patients with pancreatic neuroendocrine tumors | B Popovic, Dj Macut, M Petakov, I Bozic, T Bogavac, S Ognjanovic, T Isailovic, V Elezovic, Marijan Micev, Nemanja Menkovic, Svetozar Damjanovic | 11. Endocrine tumours and neoplasia (to include NETs) |
| P69 | Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) – is it linked to GH secretion? | D KANNAPPAN, S KENZ, S FAROOK, W MANSOOR, R NIVEN, G BRABANT | 11. Endocrine tumours and neoplasia (to include NETs) |
| P70 | FIRST PROGNOSTIC ANALYSIS OF STAGE III ADRENOCORTICAL CARCINOMA PATIENTS AFTER COMPLETE RESECTION: A RETROSPECTIVE FRENCH MULTICENTRIC STUDY FROM THE INCA-COMETE NETWORK | C. Do Cao, S. Leboulleux, I. Borget, J. Bertherat, C. De la Fouchardière, A.C. Hecart, P Caron, A. Tabarin, P. Niccoli, V. Rohmer, D. Drui, F. Schillo, I. Raingeard, J. Young, A. Ghuzlan, F. Borson-Chazot, X. Bertagna, F. Pattou, J. L. Wémeau, Z. Francis, R. Libé, S. Aubert, E. Baudin | 11. Endocrine tumours and neoplasia (to include NETs) |
| P71 | Comparison of the efficacy and the tolerance of high-dose calcium and pentagastrin tests in patients with cured or persistent medullary thyroid cancer and in controls | C Colombo, U Verga, M Perrino, L Vicentini, P Beck-Peccoz, L Fugazzola | 11. Endocrine tumours and neoplasia (to include NETs) |
| P72 | Distribution of mitotane and its two metabolites in liproprotein fractions of patients with adrenocortical carcinoma. | Y CAZAUBON, S BROUTIN, A SECK, H REMY, F LEMARE, JM BIDART, C CHOUGNET, S LEBOULLEUX, M SCHLUMBERGER, E BAUDIN, A PACI | 11. Endocrine tumours and neoplasia (to include NETs) |
| P73 | 68GA-DOTATATE PET SHOWS A BETTER DIAGNOSTIC PERFORMANCE THAN OCTREOSCAN IN PATIENTS WITH NEUROENDOCRINE TUMORS | Antongiulio Faggiano, Luigi Aloi, Corradina Caracò, Valeria Ramundo, Rosa Severino, Gaetano Lombardi, Annamaria Colao, Secondo Lastoria | 11. Endocrine tumours and neoplasia (to include NETs) |
| P74 | IN VITRO EFFECT OF SOMATOSTATIN ANALOG BIM 23704 ON CELL CYCLE TIMECOURSE IN AN OVARIAN CARCINOMA CELL LINE. | Cristina de Angelis, Claudia Pivonello, Gaia Cuomo, Attilio di Spiezio Sardo, Guiseppe Bifulco, Carmine Nappi, Francesco Sabbatino, Federica Cariati, Annamaria Colao, Rosario Pivonello | 11. Endocrine tumours and neoplasia (to include NETs) |
| P75 | T-TYPE CALCIUM CHANNEL BLOCKERS INHIBIT HORMONE SECRETION AND INDUCE APOPTOTIC CELL DEATH IN A MEDULLARY THIROID CANCER CELL LINE | R Pivonello, C Pivonello, A Cavaccini, M Sarnataro, F Cariati, A Faggiano, A Colao, M Cataldi | 11. Endocrine tumours and neoplasia (to include NETs) |
| P76 | Management of type III Neuroendocrine Tumors of the Stomach | AGJ Gilis-Januszewska, EB Baczynska, ASS Sowa-Staszczak, MT Trofimiuk, DP Pach, RT Tomaszewska, AHD Hubalewska-Dydejczyk | 11. Endocrine tumours and neoplasia (to include NETs) |
| P77 | Could 99mTc labeled long-acting agonist of GLP-1 (Exendin-4) scintigraphy be a new tool in the diagnostics of unknown focus of insulinoma ? – preliminary results. | AHD Hubalewska-dydejczyk, DP Pach, ASS Sowa-Staszczak, AJH Jabrocka-Hybel, AS Stefanska, AGJ Gilis-Januszewska, RM Mikolajczak, BJ Janota | 11. Endocrine tumours and neoplasia (to include NETs) |
| P78 | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE III TRIAL OF EVEROLIMUS + OCTREOTIDE LAR VS PLACEBO + OCTREOTIDE LAR IN PATIENTS WITH ADVANCED NEUROENDOCRINE TUMORS (NET) (RADIANT-2): UPDATED SAFETY RESULTS | D. Gross, L. Sideris, V. Jehl, S. Saletan, M. Peeters | 11. Endocrine tumours and neoplasia (to include NETs) |
| P79 | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE III TRIAL OF EVEROLIMUS IN PATIENTS WITH ADVANCED PANCREATIC NEUROENDOCRINE TUMORS (PNET) (RADIANT-3): UPDATED SAFETY RESULTS | D. Hörsch, W. Kocha, J. Lincy, S. Saletan, C. Lombard-Bohas | 11. Endocrine tumours and neoplasia (to include NETs) |
| P80 | Mitotane reduces the chemoresistance phenotype in an adrenocortical carcinoma cell line | T Gagliano, AR Robustelli, D Molè, E degli Uberti, MC Zatelli | 11. Endocrine tumours and neoplasia (to include NETs) |
| P81 | TREATMENT OF PATIENTS WITH METASTATIC WELL-DIFFERENTIATED GASTROENTEROPANCREATIC TUMORS WITH RAD001(EVEROLIMUS) | I. MPANAKA, S. ANTONIOU, G. KANAKIS, A. ZILOS, P. ROUSAKI, M. SCHINI, C. KAMPANELLOU, G. KALTSAS | 11. Endocrine tumours and neoplasia (to include NETs) |
| P82 | THE ROLE AND EXTEND OF SURGICAL RESECTION IN PATIENTS WITH GASTRIC CARCINOID TUMOURS TYPE 1 | S ANTONIOU, A ZILOS, I MPANAKA, G KANAKIS, P ROUSAKI, M SCHINI, J GRINIATSOS, GR KALTSAS | 11. Endocrine tumours and neoplasia (to include NETs) |
| P83 | Effectiveness of zolendronic acid yearly for preventing bone loss in patients with neuroendocrine tumors on somatostatin analogue therapy. | P Zdunowski, W Misiorowski, W Zgliczyński | 11. Endocrine tumours and neoplasia (to include NETs) |
| P84 | The Demethylating Agent 5-aza-2-Deoxycytidine Upregulates Somatostatin Type 2 Receptor Expression And Enhances Internalization Of Radiolabeled Somatostatin Analogue In Human Carcinoid Tumour Cells. | MJ Veenstra, P.M van Koetsveld, W.E. Farrel, F. Dogan, A.M. Waaijers, D.M. Sprij-Mooij, S.W.J. Lamberts, G. Vitale, L. Hofland | 11. Endocrine tumours and neoplasia (to include NETs) |
| P85 | Comments on a series of patients affected by MEN1 | F Veltri, A Fusco, F Lugli, A D'Uonnolo, M Lorusso, V Cimino, A Pontecorvi, L De Marinis | 11. Endocrine tumours and neoplasia (to include NETs) |
| P86 | Role of peptide receptor radionuclide therapy (PRRT) in well and moderately differentiated neuroendocrine tumours | A Bianchi, D Milardi, D Iacovazzo, L Tartaglione, G Grande, S Piacentini, A Pontecorvi, L De Marinis | 11. Endocrine tumours and neoplasia (to include NETs) |
| P87 | ANATOMICAL DISTRIBUTION OF PRIMARY ADRENAL TUMORS. TEN YEAR SINGLE CENTER EXPERIENCE | A. Gkountouvas, I. Kostoglou-Athanassiou, I. Keramidas, F. Chatzimarkou, M. Nikas, D. Thomas, P. Georgiadis, P. Kaldrymidis | 11. Endocrine tumours and neoplasia (to include NETs) |
| P88 | cAMP induces PATZ1 and estrogen receptor beta nuclear re-localization in the human seminoma TCam-2 cell line. | F Boscia, F Esposito, S Kitazawa, L Looijenga, P Chieffi | 11. Endocrine tumours and neoplasia (to include NETs) |
| P89 | The management of thyroid nodule in a patient with a non-thyroid primary cancer | Rene Baloescu, Mara Carsote, Raluca Trifanescu, Madalina Musat, Ruxandra Danciulescu-Miulescu, Dumitru Ioachim, Dana Terzea, Catalina Poiana | 11. Endocrine tumours and neoplasia (to include NETs) |
| P90 | Ovulation Induction by Metformin in Lean and Obese Women with Polycystic Ovary Syndrome. | P.V. Popova, L.I. Ivanova, T.L. Karonova, E.N. Grineva | 12. Female Reproduction |
| P91 | Detection and Exploring the Left Shift Kurtosis of the Fertile Window in Ovulatory Cycles by Biophysical Biomarkers of the Cervical Secretion: Case Report | Jose María Murcia Lora, María Luisa Esparza Encina | 12. Female Reproduction |
| P92 | Prevalence of thyroid pathologies in patients with polycystic ovary syndrome | Didem Ozdemir, Neslihan Cuhaci, Fevzi Balkan, Alper Usluogullari, Reyhan Ersoy, Bekir Cakir | 12. Female Reproduction |
| P93 | Metformin treatment with or without life style changes in the polycystic ovary syndrome | G PETRÁNYI, M ZAOURA-PETRÁNYI | 12. Female Reproduction |
| P94 | Development of a mouse model with polycystic ovary syndrome | E.L.A.F van Houten, A. Mcluskey, P. Kramer, B. Karels, A.P.N. Themmen, J.A. Visser | 12. Female Reproduction |
| P95 | Kisspeptin: new marker of placental dysfunction? | D Miljic, A Cetkovic, A Ljubic, P Miljic, M Djurovic, M Doknic, S Pekic, M Stojanovic, M Patterson, M Ghatei, S Bloom, V Popovic | 12. Female Reproduction |
| P96 | Tissue specific regulation of CGB gene expression in the common marmoset (Callithrix jacchus) by SP-1 and AP-2 | C Adams, J Gromoll | 12. Female Reproduction |
| P97 | SEXUAL DYSFUNCTION IN POLYCYSTIC OVARY SYNDROME | Selvinaz Velet, Mustafa Velet, Pinar Kadioglu, Sezai Sahmay | 12. Female Reproduction |
| P98 | Oligo-amenorrhea and hyperandrogenaemia in postmenarchal adolescence | P. Pinola, H. Lashen, A. Bloigu, K. Puukka, M. Ulmanen, MR. Järvelin, AL. Hartikainen, L. Morin-Papunen | 12. Female Reproduction |
| P99 | Cardiovascular disease risk markers in women with polycystic ovary syndrome: systematic review and meta-analysis. | KA Toulis, G Mintziori, DG Goulis, E Kintiraki, E Eukarpidis, SA Mouratoglou, A Pavlaki, S Stergianos, M Poulasouhidou, TG Tzellos, BC Tarlatzis | 12. Female Reproduction |
| P100 | The aldosterone/renin ratio during administration of oral contraceptives with different types of gestogens | Z. Locsei, D. Horvath, Zs. Csizmadia, E. Toldy, GL. Kovacs, K. Racz | 12. Female Reproduction |
| P101 | Inhibitory effect of DHEAS on leiomyoma growth | M Han, M Cha, I Choi, H Ahn, J Byun | 12. Female Reproduction |
| P102 | The importance of PΙΚ3R1 gene in polycystic ovary syndrome | N XITA, A CHATZIKYRIAKIDOU, I GEORGIOU, A TSATSOULIS | 12. Female Reproduction |
| P103 | EFFECT OF PARAOXONASE GENES ON METABOLIC PROFILE OF WOMEN WITH POLYCYSTIC OVARY SYNDROME | N XITA, L LAZAROS, I GEORGIOU, A TSATSOULIS | 12. Female Reproduction |
| P104 | Glucocorticoid-Induced Leucine Zipper (GILZ), a factor which controls tumor cell proliferation, is estradiol responsive in epithelial ovarian cancer | V MACHELON, N REDJIMI, F GAUDIN, L DELBOS, D EMILIE, S PREVOT, K BALABANIAN | 12. Female Reproduction |
| P105 | rs7566605 SNP of INSIG2 gene is not associated with the polycystic ovary syndrome diagnosis and its phenotypic traits in Romanian subjects | D Aflorei, S Radian, N Baculescu, M Gheorghiu, S Fica, A Albu, F Grigorescu, M Coculescu | 12. Female Reproduction |
| P106 | C-peptide serum concentration in obese women with polycystic ovary syndrome | MMJ Maciejewska-Jeske, AS Szczesna, BM Meczekalski | 12. Female Reproduction |
| P107 | Higher Metabolic Risk with NIH diagnostic criteria versus Rotterdam criteria for polycystic ovarian syndrome | Inan Anaforoglu, Ekrem Algun, Omer Incecayir, Kerem Ersoy | 12. Female Reproduction |
| P108 | Relation of insulin resistance and lipid peroxidation in non-obese women with polycystic ovary syndrome | D Macut, A Lissounov, I Bozic, T Simic, J Bjekic, M Petakov, S Damjanovic, A Savic-Radojevic | 12. Female Reproduction |
| P109 | PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis | P.C.M. de Groot, O.M. Dekkers, J.A. Romijn, S.W.M. Dieben, F.M. Helmerhorst | 12. Female Reproduction |
| P110 | MTHFR Mutations in Female Patients with Autoimmune Thyroiditis | Alexandra Bulgar, Andreea Brehar, Diana Paun, Constantin Dumitrache | 12. Female Reproduction |
| P111 | Plasma testosterone fractions in women with hyperandrogenism | E. Toldy, D. Horvath, Z. Locsei, K. Racz, GL. Kovacs | 12. Female Reproduction |
| P112 | POLYCYSTIC OVARY SYNDROME AND AUTOIMMUNITY | J. Petrikova, D. Kozakova, J. Vrbikova, Y. Shoenfeld, I. Lazurova | 12. Female Reproduction |
| P113 | 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (71A/G HSD17B5 SNP) and effects of oral contraceptive pill on hirsutism, androgens and metabolic profile in non-obese PCOS women: a pilot study | PS Maier, SS Mattiello, L Lages, PM Spritzer | 12. Female Reproduction |
| P114 | Does Uric Acid Predict Insulin Resistance In Polycystic Ovary Syndrome? | O Oz Gul, C Ersoy, B Gul, S Cander, O.K Unal, E Erturk, E Tuncel, S Imamoglu | 12. Female Reproduction |
| P115 | Injected FSH overriding ageing related elevated FSH through high activity of the hypothalomo-pituitary axis, enforces wanted multiple follicle growth in women undergoing IUI | T.E. König, S.N. Beemsterboer, A. Overbeek, M.L. Hendriks, M.W. Heymans, P. Hompes, R. Homburg, R. Schats, C.B. Lambalk | 12. Female Reproduction |
| P116 | The influence of LH substitution for GnRH antagonist blocked endogenous LH in older IVF patients | T.E. König, L.E.E. van der Houwen, S.N. Beemsterboer, A. Overbeek, M.L. Hendriks, W.K. Kuchenbecker, R.E. Bernardus, P. Hompes, R. Schats, R. Homburg, C.B. Lambalk | 12. Female Reproduction |
| P117 | Adiponectin and metabolic syndrome in PCOS patients – beyond obesity | L Leustean, S Fica, C Preda, MC Ungureanu, C Cristea, S Mogos, V Mogos, C Vulpoi | 12. Female Reproduction |
| P118 | Ovarian ageing and twinning | E. van der Stroom, T.E. König, D.I. Boomsma, C.B. Lambalk | 12. Female Reproduction |
| P119 | The role of metabolic hormones ghrelin, leptin and obestatin in control of ovarian functions | Alexander Sirotkin, Monika Meszarosova, Roland Grossmann, Marina Korzhenevskaja, Andrej Benco, Silvia Pavlova | 12. Female Reproduction |
| P120 | Smoking is associated with increased adrenal responsiveness, decreased prolactin levels and a more adverse lipid profile in 650 Caucasian patients with polycystic ovary syndrome | D Glintborg, H Mumm, DM Hougaard, P Ravn, M Andersen | 12. Female Reproduction |
| P121 | Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest | I Fraser, J Jensen, M Schäfers, U Mellinger, S Parke, M Serrani | 12. Female Reproduction |
| P123 | Self-reported health related quality of life and depression in women with polycystic ovary syndrome: associations with selected metabolic and hormonal PCOS features. | Jana Vrbikova, Martin Hill, Marketa Vankova, Ioannis Kyrou | 12. Female Reproduction |
| P124 | Two hormone for one receptors: dissecting out LH and hCG activity with an in vitro approach. | Livio Casarini, Antonio La Marca, Elisa Pignatti, Manuela Simoni | 12. Female Reproduction |
| P125 | Anti-Müllerian Hormone as a Predictor of Ovarian Response to Metformin in Lean Women with Polycystic Ovary Syndrome | P.V. Popova, I.E. Zazerskaya, L.I. Ivanova, T.L. Karonova, E.N. Grineva | 12. Female Reproduction |
| P126 | Cigarette smoking and progesterone and androgen metabolites in premenopausal women | Michaela Duskova, Katerina Simunkova, Martin Hill, Hana Hruskovicova, Hana Pospisilova, Eva Kralikova, Luboslav Starka | 12. Female Reproduction |
| P127 | Influence of smoking cessation on steroid spectrum in premenopausal women | Hana Pospisilova, Michaela Duskova, Katerina Simunkova, Hana Hruskovicova, Martin Hill, Eva Kralikova, Luboslav Starka | 12. Female Reproduction |
| P128 | METABOLIC AND CARDIOVASCULAR OUTCOMES IN ADULT PATIENTS WITH TURNER’S SYNDROME UNDER HORMONAL REPLACEMENT THERAPY | R Giordano, D Forno, M Baldi, F Lanfranco, E Ghigo | 12. Female Reproduction |
| P129 | Extreme ketogenic, but not moderate, low-carbohydrate/high fat diets lead to loss of lean body mass in rats due to impairments of the GH/IGF system | M. Bielohuby, M. Sawitzky, B. Stoehr, J. Ramisch, D. Menhofer, A. Hoeflich, M. Bidlingmaier | 13. Growth factors |
| P130 | Zilpaterol hydrochloride effects on carcass composition, growth performance and blood metabolites of Lory Bakhtyary lambs | Y. Khalifeloo, S. Zeinoaldini, A. Towhidi, A. Zali, M. Moradi Shahre Babak, A. Hatefi | 13. Growth factors |
| P131 | COMPARATIVE CHARACTERIZATION OF INFLUENCE OF REPLACEMENT THERAPY WITH GROWTH HORMONE ON THE LEVEL OF SECRETION OF GROWTH HORMONE, INSULIN-LIKE GROWTH FACTOR-1 AND BINDING PROTEIN-3 IN GIRLS WITH ENDOCRINE AND HEREDITARY TYPES OF STUNTING | Nilufar Ibragimova | 13. Growth factors |
| P132 | BONE TURNOVER AND MINERAL DENSITY IN THALASSEMIA: RELATIONSHIPS WITH GH SECRETORY STATUS AND CIRCULATING SOMATOMEDINS | Leila Danesi, Agnese Cattaneo, Massimo Scacchi, Giovanna Sciortino, Giovanni Vitale, Maria Domenica Cappellini, Marica Arvigo, Diego Ferone, Francesco Minuto, Francesco Cavagnini | 13. Growth factors |
| P133 | Effects of the d3 GHR allele on disease activity in acromegalic patients | S Kohler, R Bernays, C Zwimpfer, P Wiesli, Ch Schmid | 13. Growth factors |
| P134 | Circulating insulin-like growth factor 1 (IGF-1) and mortality: meta-analysis and dose-response meta-regression | AMG Burgers, NR Biermasz, JW Schoones, AM Pereira, AG Renehan, M Zwahlen, M Egger, OM Dekkers | 13. Growth factors |
| P135 | Long acting analogs of glycoprotein hormones developed by using gene fusion and gene transfer are safe for use in human | Fuad Fares, Avri Havron, Eyal Fima | 13. Growth factors |
| P136 | Experience with a 1% testosterone gel in treatment of aging males with hypogonadism and type 2 diabetes mellitus | Olga Vasilkova, Tatiana Mokhort | 14. Male Reproduction |
| P137 | HYPOGONADISM, INSULIN RESISTANCE AND VISCERAL ADIPOSITY IN MYOTONIC DYSTROPHY | E Passeri, E Bugiardini, V Sansone, C Fulceri, E Costa, B Ambrosi, G Meola, S Corbetta | 14. Male Reproduction |
| P138 | Perceived ejaculate volume reduction in subjects with erectile dysfunction: psycho-biological correlates | Giovanni Corona, Valentina Boddi, Mauro Gacci, Alessandra Sforza, Gianni Forti, Edoardo Mannucci, Mario Maggi | 14. Male Reproduction |
| P139 | Perceived reduced sleep-related erections in subjects with erectile dysfunction: psycho-biological correlates | Giovanni Corona, Giulia Rastrelli, Alessandra Sforza, Gianni Forti, Edoardo Mannucci, Mario Maggi | 14. Male Reproduction |
| P140 | Sexual Interests and Hypogonadism in Prader-Willi Syndrome (PWS) | HJ Hirsch, T Eldar-Geva, F Benarroch, O Rubinstein, V Gross-Tsur | 14. Male Reproduction |
| P141 | ERECTILE DYSFUNCTION DOES NOT MIRROR ENDOTHELIAL DYSFUNCTION IN HIV-INFECTED PATIENTS | D Santi, M Beggi, G Brigante, S Zona, K Luzi, G Orlando, R Rossi, P Bouloux, G Guaraldi, V Rochira | 14. Male Reproduction |
| P142 | P450 aromatase over-expressing mice (AROM+) as a model for infertility in men | L Strauss, M Adam, A Mayerhofer, M Poutanen | 14. Male Reproduction |
| P143 | THE OBSTRUCTIVE AZOOSPERMIA AND TESA-ICSI | B Colak, M Sunjic Stakor, K Peros, J Zmire, K Kljajic | 14. Male Reproduction |
| P144 | Does local testosterone therapy in adult men measure up to the 2006 Endocrine Society’s Guidelines? | D Hughes, A Toogood | 14. Male Reproduction |
| P145 | Criptorchidism, varicocele, azoospermia and Leydig cell tumor in a couple of identical twins with a unique de novo balanced reciprocal translocation. | M. Vetri, A. Stancampiano, L. Licciardello | 14. Male Reproduction |
| P146 | Transcriptional regulation of germ cell differentiation. | JM Weitzel | 14. Male Reproduction |
| P147 | Efficacy of recombinant human follicle-stimulating hormone (rhFSH) in the treatment of male-factor infertility. | M. Vetri, A. Stancampiano, S. Crimi | 14. Male Reproduction |
| P148 | Testosterone changes over time in men with Human Immunodeficiency Virus Infection: preliminary results | G Brigante, D Santi, L Zirilli, C Diazzi, G Orlando, V Gnarini, C Carani, G Guaraldi, V Rochira | 14. Male Reproduction |
| P149 | Intramuscular testosterone undecanoate for substitution in male hypogonadism – the experience of 13.5 years | F. Saad, M. Zitzmann | 14. Male Reproduction |
| P150 | Testosterone administration to hypogonadal men for a period of up to 42 months improves features of the metabolic syndrome | F. Saad, A. Haider, A. Yassin, L. Gooren | 14. Male Reproduction |
| P151 | Safety of 42 months of treatment with of long-acting parenteral testosterone undecanoate in men with late-onset hypogonadism | F. Saad, A. Haider, A. Yassin, L. Gooren | 14. Male Reproduction |
| P152 | Expression of ghrelin receptor GHSR-1a in mammalian spermatozoa and their response to ghrelin in vitro | Andrzej Lukaszyk, Malgorzata Kotwicka, Anna Jankowska, Marcin Rucinski, Aldona Kasprzak, Karolina Sterzynska, Agnieszka Ziolkowska, Marek Ruchala | 14. Male Reproduction |
| P153 | LOWER SERUM TESTOSTERONE (T) AND ESTRADIOL (E2) IN ADULT MEN WITH UNFUSED EPIPHYSES DUE TO UNRECOGNIZED AND UNTREATED CONGENITAL HYPOGONADOTROPIC HYPOGONADISM (HH): EVIDENCE FOR AN E2 THRESHOLD FOR BONE MATURATION IN MEN | V ROCHIRA, A BALESTRIERI, L ZIRILLI, B MADEO, I SGARBI, A LUBERTO, C CARANI | 14. Male Reproduction |
| P154 | ERECTILE DYSFUNCTION IN ENDOCRINE PATIENTS (PITUITARY DISEASES) | Simona Juliette Mogos, Camen Vulpoi, Teodora Ananie, Voichita Mogos, Eusebie Zbranca | 14. Male Reproduction |
| P155 | Short-term balneotherapy is associated with changes in salivary cortisol levels | F Matzer, B Bahadori, C Fazekas | 15. Neuroendocrinology |
| P156 | Character of macrovascular complications as per the Uzbekistan National Register of patients with the combined diabetes mellitus and diabetes insipidus | S.I. Ismailov, Z.Yu. Khalimova, Yu.M. Urmanova, D.A. Alieva | 15. Neuroendocrinology |
| P157 | Clinical presentation peculiarities of constitutional puberty delay in boys | Yu.M. Urmanova, U.Kh. Mavlonov | 15. Neuroendocrinology |
| P158 | Evaluation of the questionnaire for revealing of growth hormone deficiency in adults with various pituitary adenomas | M.Yu. Shakirova | 15. Neuroendocrinology |
| P159 | "Frequency of Secondary Growth Hormone Deficit in patients with Acromegaly undergone radiation or surgical treatment". | Yu.M. Urmanova, M.Yu. Shakirova | 15. Neuroendocrinology |
| P160 | Hormonal disorders in patients with acromegaly in Khorezm region, Republic of Uzbekistan | S.I. N.T., Rikhsieva Urmanova, Sh.O. Khodjaev, Sh.A. Eshmetov, M.A. Rakhmetova, F.S. Khodjaeva, B.A. Azizov | 15. Neuroendocrinology |
| P161 | Incidence of diabetes mellitus and diabetes insipidus combination in the Republic of Uzbekistan | Z.Yu. Khalimova, Yu.M. Urmanova, D.A. Alieva, V. Aripova | 15. Neuroendocrinology |
| P162 | "Incidence of puberty delay risk factors in boys" | Yu.M. Urmanova, U.Kh. Mavlonov | 15. Neuroendocrinology |
| P163 | Structure of neuroendocrine disorders rate in patients with different pituitary adenomas (retrospective analysis). | M.Yu. Shakirova | 15. Neuroendocrinology |
| P164 | Sexual desire in female-to-male transsexuals | K Wierckx, F Van De Peer, D Dedecker, E Van Caenegem, E Elaut, G T'Sjoen | 15. Neuroendocrinology |
| P165 | ROLE OF IGF-I SYSTEM IN HUMAN LONGEVITY. A STUDY IN A WIDE POPULATION OF CENTENARIANS AND CENTENARIANS’ OFFSPRING | G. Vitale, M.P. Brugts, G. Ogliari, D. Castaldi, L.M. Fatti, L.J. Hofland, D. Monti, F. Cavagnini, C. Franceschi, D. Mari, J.A.M.J.L. Janssen | 15. Neuroendocrinology |
| P166 | Evaluation of insulin secretion and sensitivity and lipid profile in Growth Hormone (GH) deficient children before and at the end of rhGH therapy. | F Prodam, S Savastio, S Bellone, C Balossini, R Ricotti, G Genoni, G Aimaretti, G Bona | 15. Neuroendocrinology |
| P167 | Immune status and functional activity of blood neutrophils in patients with active acromegaly | M.A. Dudina, S.A. Dogadin, A.A. Savchenko | 15. Neuroendocrinology |
| P168 | Dexamethasone supression test (BDST) and bilateral inferior petrosal sinus sampling (BIPSS) in diagnosis of ACTH - dependent hypercortisolism | A. Dreval, I. Komerdus, T. Britvin, I. Demidov, O. Nechaeva, A. Murzina, L. Denisova | 15. Neuroendocrinology |
| P169 | The NAD- and NADP-dependent blood lymphocytes dehydrogenases activity in acromegaly | M.A. Dudina, S.A. Dogadin, A.A. Savchenko | 15. Neuroendocrinology |
| P170 | METABOLIC ENCEPHALOPATHY AND QUADRIPARESIS INDUCED BY SEVERE HYPONATREMIA IN THE PATIENT WITH SY SEEHAN | Jelena Bogdanovic, Radmila Stojanovic Perusko, Dragana Popovic, Radojka Dzomlija, Vera popovic, Marko Ercegovac, Ljiljana Bogdanovic, Dusan Micic | 15. Neuroendocrinology |
| P171 | Effects of orexin-monoaminergic interactions on vasopressin secretion in rat neurohypophyseal cell cultures | G.K. Kis, M. Gálfi, M. Radács, K. Kádár, Z. Molnár, A.H. Molnar, F. László, C. Varga, F.A. László | 15. Neuroendocrinology |
| P172 | Age related distribution of the endothelial nitric oxide synthase gene G894T polymorphism: relationship with metabolic-endocrine and cognitive features | O Ianas, D Manda, C Heltianu, S Vladoiu, O Popa, R Rosca, S Oros, M Covic, O Joja | 15. Neuroendocrinology |
| P173 | Glucose homeostasis in growth hormone deficient adults not treated with growth hormone: more than 10 year follow-up | S Pekic Djurdjevic, M Doknic, M Stojanovic, D Miljic, M Djurovic, M Medic Stojanoska, V Popovic | 15. Neuroendocrinology |
| P174 | A RAISED GR ALPHA/BETA EXPRESSION RATIO IN MONOCYTES OF SCHIZOPHRENIC AND BIPOLAR PATIENTS | K Weigelt, A Spijker, R.C. Drexhage, A.M. Wijkhuijs, H.A. Drexhage | 15. Neuroendocrinology |
| P175 | The role of food choice in the effects of a high-fat high-sugar diet on leptin sensitivity | J.K. van den Heuvel, L. Eggels, M.C.M. Luijendijk, A. Kalsbeek, E. Fliers, R.A.H Adan, S.E. la Fleur | 15. Neuroendocrinology |
| P176 | Hypothalamic neuropeptide Y controls the hepatic secretion of VLDL triglycerides in rats via the sympathetic nervous system | E. Bruinstroop, L. Pei, M. Ackermans, E. Fliers, A. Kalsbeek | 15. Neuroendocrinology |
| P177 | INVERSE ASSOCIATION OF DEHYDROEPIANDROSTERONE SULFATE WITH STROKE SEVERITY AND POOR FUNCTIONAL OUTCOME IN A FEMALE STROKE POPULATION | T Pappa, K Vemmos, K Saltiki, E Mantzou, K Stamatelopoulos, M Alevizaki | 15. Neuroendocrinology |
| P178 | Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations | B Francou, J Bouligand, A Voican, L Amazit, S Brailly-Tabard, P Lecomte, J Young, A Guiochon-Mantel | 15. Neuroendocrinology |
| P179 | X-linked adrenoleukodystrophy: an intersection between Endocrinology and Neurology | S. Gouveia, L. Gomes, C. Ribeiro, A. Vieira, M. Alves, J. Saraiva, M. Carvalheiro | 15. Neuroendocrinology |
| P180 | Targeting PKC in Human Pancreatic Neuroendocrine Tumor Cells | D Molè, T Gagliano, E Gentilin, M Bondanelli, F Tagliati, E degli Uberti, MC Zatelli | 15. Neuroendocrinology |
| P181 | Growth Hormone enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis | M Minoia, E Gentilin, F Tagliati, D Molè, MR Ambrosio, A Baroni, E degli Uberti, MC Zatelli | 15. Neuroendocrinology |
| P182 | Glycoproteic pituitary hormones in the cerebrospinal fluid of patients with pituitary adenomas | M. Coculescu, C. Capatina, A. Caragheorgheopol, A. Dumitrascu, D. Hortopan, M. Raica, A.M. Cimpean, S. Constantinoiu, C. Gandea | 15. Neuroendocrinology |
| P183 | Hipothalamo-pituitary-adrenal axis function in posttraumatic stress disorder | I Bozic, D Macut, B Popovic, T Isailovic, M Petakov, S Ognjanovic, T Bogavac, S Damjanovic | 15. Neuroendocrinology |
| P184 | Vasopressin and vasopressin receptor expression in the rodent retina | C Saunders, I Rowe, H Widmer, M Ludwig | 15. Neuroendocrinology |
| P185 | Serum leptin levels in patients with Alzheimer’s disease | A.A Rizoulis, S.E Karaoulanis, E Dardiotis, K.A Rizouli, A Bargiota, G.M Hadjigeorgiou, A Papadimitriou | 15. Neuroendocrinology |
| P186 | Estrogen signaling in the hypothalamus regulates glucose metabolism in female rats | J Liu, P Bisschop, L Eggels, E Foppen, JN Zhou, E Fliers, A Kalsbeek | 15. Neuroendocrinology |
| P187 | The role of the Diphereline (Triptoreline) test in the etiological diagnosis of gonadal dysfunction | Ruxandra Dobrescu, Roxana Militaru, Simona Jercalau, Vadim Gavan, Andra Caragheorgheopol, Corin Badiu | 15. Neuroendocrinology |
| P188 | Glucocorticoid receptor gene polymorphisms are associated with disease course during pregnancy and the post-partum period in rheumatoid arthritis. | R.A.M. Quax, Y.A. de Man, J.W. Koper, S.P. Willemsen, S.W.J. Lamberts, J.M.W. Hazes, R.J.E.M Dolhain, R.A. Feelders | 15. Neuroendocrinology |
| P189 | Cabergoline influence on antioxidative protection enzymes activity in complex therapy in patients with non-functioning pituitary adenoma (NFPA) | S.I Ismailov, Z.Yu Khalimova, D.Sh Kholova | 15. Neuroendocrinology |
| P190 | THE ROLE OF CENTRALLY APPLIED GHRELIN ON HYPOTHALAMIC AMPK ACTIVITY AND PITUITARY-ADRENAL RESPONSES IN DIFFERENTLY FED RATS | Darko Stevanovic, Verica Milosevic, Dejan Nesic, Dragan Micic, Mirjana Sumarac-Dumanovic, Vera Popovic, Vesna Starcevic | 15. Neuroendocrinology |
| P191 | THE TREATMENT WITH DOPAMINE AGONISTS ARE NOT ASSOCIATED WITH INCREASED PREVALENCE OF CARDIAC-VALVE REGURGITATION IN PATIENTS WITH PROLACTINOMAS AND ACROMEGALIA. | M PUMA, B LECUMBERRI, A FERNÁNDEZ, F DOMÍNGUEZ, M MARTÍN, M YANGÜELA, L PALLARDO, C ÁLVAREZ | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P192 | Adipocytes as a Source of Increased Circulating Levels of NAMPT/ Visfatin in Active Acromegaly | C Olarescu, T Ueland, T Lekva, T B Dahl, P Aukrust, B Halvorsen, J Bollerslev | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P193 | Pituitary mycosis complicating a Cushing’s macroadenoma | V Edirisinghe, P Goulden, J Powrie, J Kumar | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P194 | IMMUNOPOSITIVE ACTH CELLS IN JUVENILE FEMALE RATS AFTER TREATMENT WITH ESTRADIOL | V Milosevic, V Ajdzanovic, D Todorovic, B Sosic-Jurjevic, B Filipovic, N Nestorovic, J Pantelic, M Sekulic | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P195 | A Case of An Ectopic Prolactinoma | I YILDIRIM SIMSIR, G UNAL KOCABAS, O OZDEMIR, FB OZTURK CEYHAN, BP SARER YUREKLI, M ERDOGAN, AG OZGEN | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P196 | Coping strategies in patients after treatment for functioning or non-functioning pituitary adenomas | J. Tiemensma, A.A. Kaptein, A.M. Pereira, J.W.A. Smit, J.A. Romijn, N.R. Biermasz | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P197 | Polycystic Ovary Syndrome and prolactinoma association. J.Marti Department of Internal Medicine Hospital Zumarraga.Guipuzcoa.Spain | j marti | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P198 | Effects on metabolic parameters after 12-month treatment with a new once-a-week sustained release recombinant growth hormone (LB03002) in adult patients with GH deficiency (GHD) | J Roemmler, A Gockel, B Otto, M Bidlingmaier, J Schopohl | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P199 | Fifteen years of Growth Hormone (GH) Replacement Increases Bone Mineral Density in Hypopituitary Patients with Adult Onset GH Deficiency | M Elbornsson, G Götherström, B-Å Bengtsson, G Johannsson, J Svensson | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P200 | Effects of 3-year growth hormone (GH) replacement therapy on bone mineral density in younger and elderly adults with adult onset GH deficiency | M Elbornsson, G Götherström, C Franco, B-Å Bengtsson, G Johannsson, J Svensson | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P201 | Evaluation of Aortic Stiffness in The Acromegaly Patients With Remission | Eylem Karatay, Erman Cakal, Gulsum Gonulalan, Mehmet Dogan, Nujen Colak Bozkurt, Mustafa Ozbek, Tuncay Delibasi | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P202 | Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiation therapy | M Elbornsson, G Götherström, B-Å Bengtsson, G Johannsson, J Svensson | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P203 | Effects of dopamine agonist on heart and lung in patients receiving dopamine agonist due to hyperprolactinemia | Cigdem Tacyildiz, Hatice Sebila Dokmetas, Fatih Kilicli, Tamer Dogan, Hasan Arslanturk | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P204 | Efficacy of transsphenoidal surgery in treatment of Cushing’s disease: factors influencing postsurgical outcome. | Natalia Molitvoslovova, Elizaveta Mamedova, Andrey Grigoryev, Galina Kolesnikova, Lyudmila Rozhinskaya, Svetlana Arapova, Evgeniya Marova | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P205 | LHRH-antagonist Cetrorelix may reduce Postmenopausal Flushing | P.M. van Gastel, M. van der Zanden, D. Telting, M. Filius, L. Bansci, H. de Boer | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P206 | O-6 methylguanine-DNA methyl transferase (MGMT) immunoexpression in growth hormone (GH) secreting pituitary adenomas and it’s correlation with Ki-67 labeling index ( Ki-67 LI) | Sayid Shafi Zuhur, Canan Tanik, Ozcan Karaman, Esra Cil, Selvinaz Velet, Feyza Yener Ozturk, Ahmet Murat Musluman, Yuksel Altuntas | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P207 | Mechanism of Anterior Pituitary Gene Regulation by LHX3 in Paediatric Combined Pituitary Hormone Deficiency | R Malik, C Hunter, S Colvin, S Rhodes | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P208 | High risk of central adrenal insufficiency in GH deficient long-term survivors of childhood acute lymphoblastic leukaemia | C Follin, K Link, C Moëll, T Wiebe, E-M Erfurth | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P209 | Rationale and Design of a Global Hyponatraemia Registry | J Verbalis, A Greenburg, P Gross | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P210 | Screening of Cushing’s syndrome and Acromegaly in Japanese diabetic patients. | A Hirai, S Nagai, H Kameda, N Wada, J Takeuchi, H Kijima, T Kondo, H Miyoshi, C Shimizu, T Koike | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P211 | GENDER-RELATED DIFFERENCES IN PROLACTINOMAS | A Ramos-Prol, R Cámara-Gómez, B León-de Zayas, A Beltrán, JA Simal, M Argente-Pla, MI del Olmo-García, JF Merino-Torres | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P212 | Efficacy and safety of the use of the recombinant GH receptor antagonist pegvisomant (PGV) in Acromegaly. Evaluation of its use in 13 patients treated in a pituitary disorders unit | M Domínguez-López, I González-Molero, J García-Arnés | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P213 | Hypothalamic tumor in a patient with Pendred syndrome | A Giestas, M Almeida, S Teixeira, A Maia, T Azevedo, D Vaz, A Carvalho, R Carvalho | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P214 | Multimodal treatment and minimally invasive surgery for 117 pituitary adenomas: a Croatian Pituitary Centre experience | Ivan Kruljac, Andreja Maric, Petra Sulentic, Maja Berkovic Cigrovski, Davorka Herman Mahecic, Gorana Mirosevic, Darko Kastelan, Milan Vrkljan | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P215 | Illness perceptions, quality of life and self-reported physical symptoms in patients after long-term remission of Cushing’s syndrome | J. Tiemensma, A.A. Kaptein, A.M. Pereira, J.W.A. Smit, J.A. Romijn, N.R. Biermasz | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P216 | Long-term treatment of acromegaly with pegvisomant (Somavert®) – cross-sectional observations from ACROSTUDY, a post-marketing, international, safety, surveillance study. | A-J van der Lely, F Lundgren, BMK Biller, T Brue, J Cara, E Ghigo, J Hey-Hadavi, N Rajicic, Bernhard Saller, John Sanocki, Christian Strasburger, Susan Webb, Maria Koltowska-Haggstrom | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P217 | Pituitary Gland Function Following Craniocerebral Trauma III° in Younger Patients | R. Hampel, S. Ziems, Ch. Zingler, A. Gabert | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P218 | MACROPROLACTINOMAS IN 38 CHILDREN AND ADOLESCENTS: SEX DIFFERENCES AND LONG-TERM RESULTS OF MEDICAL TREATMENT | DA Ancelle, GR Raverot, BD Découdier, SV Sulmont, MN Nicolino, PB Berlier, FBC Borson-Chazot, BD Delemer | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P219 | MEDICAL TREATMENT OF AN AGRESSIVE NON-SECRETING PITUITARY TUMOR AND NON-SECRETING PITUITARY CARCINOMA: A REPORT OF TWO CASES | K. Bajuk Studen, M. Pfeifer | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P220 | Normal pregnancy in a woman with history of panhypopituitarism due to lymphocytic hypophysitis | D V Dimarakis, C T Tsentidis, A A Antoniou-Tsigos, A A Argyropoulos | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P221 | PANCH tumor in a female patient | C T Tsentidis, A A Antoniou-Tsigos, V D Dimarakis, G S Georgakopoulou, P I Prokovas, A A Argyropoulos | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P222 | ON THE EFFECT OF CRH AND DEXAMETHASONE ON POMC SYNTHESIS AND ACTH SECRETION IN RAT PITUITARY PRIMARY CULTURES | M.F. Cassarino, L. Pagliardini, F. Cavagnini, F. Pecori Giraldi | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P223 | KIT protein expression and mutational status of KIT gene in pituitary adenomas | O. Casar-Borota, S.L. Fougner, J. Bollerslev, J.M. Nesland | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P224 | Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly | C L Ronchi, E Verrua, E Ferrante, G Bender, E Sala, A Lania, M Fassnacht, P Beck-Peccoz, Bruno Allolio, Anna Spada, Maura Arosio | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P225 | Effect of Growth Hormone as add-on treatment in severe fibromyalgia syndrome. Results from the IIIb, CT27560 placebo-controlled, multicenter trial. | Guillem Cuatrecasas, Cayetano Alegre, Joaquim Fernandez-Sola, Maria Jose Gonzalez, Mary Lage, Gemma Sesmilo, Enrique Granados, Manuel Puig-Domingo | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P226 | TUMOR OCCURRENCE OR RECURRENCE AFTER FIVE YEAR GH REPLACEMENT THERAPHY | MC Savanelli, E Scarano, V Brunelli, G Lombardi, A Colao, C Di Somma | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P227 | PITUITARY FUNCTION IN TYPE 2 DIABETIC MEN WITH GOOD OR POOR GLYCAEMIC CONTROL | S Scaltriti, B Madeo, M Bertolini, S Romano, L Zirilli, E R Cavani, A Balestrieri, C Carani, V Rochira | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P228 | Non-traditional effects of growth hormone: A survival factor for retinal ganglion cells. | S Harvey, W Lin, E Parker, E Sanders | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P229 | Clinical and subclinical apoplexy in nonfunctioning pituitary tumors: clinical features, management and outcome | Leonor Gomes, Isabel Paiva, Cristina Ribeiro, Jacinta Santos, Alexandra Vieira, Márcia Alves, Sofia Gouveia, Joana Saraiva, Olinda Rebelo, Manuela Carvalheiro | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P230 | Comparison of growth hormone suppression response after oral and intravenous glucose tolerance tests in healthy subjects | Cevdet Aydin, Reyhan Ersoy, Didem Ozdemir, Neslihan Cuhaci, Dilek Arpaci, Alper Usluogullar, Yusuf Ustu, Husniye Baser, Ahmet Dirikoc, Bekir Cakir | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P231 | THE RELIABILITY OF GROWTH HORMONE STIMULATION TESTS IN THE DIAGNOSIS OF CHILDHOOD GH DEFICIENCY | Zs. Szanto, I.Z. Kun, K. Gergely, J. Balazs, A. Nasalean | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P232 | Copeptin in the differential Diagnosis of the Polydipsia-Polyuria Syndrome – revisiting the direct and indirect Water Deprivation Tests | W.K. Fenske, M. Quinkler, U. Haagen, J. Papassotiriou, A.F.H. Pfeiffer, M. Fassnacht, S. Stoerk, B. Allolio | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P233 | Growth hormone replacement therapy in elderly growth hormone deficient patients: a systematic review | N.E. Kokshoorn, N.R. Biermasz, F. Roelfsema, J.W.A. Smit, A.M. Pereira, J.A. Romijn | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P234 | Does Growth Hormone Replacement Therapy reduce Mortality in Adults with Growth Hormone Deficiency? – Data from the Dutch National Registry of Growth Hormone Treatment in Adults | C.C. van Bunderen, I.C. van Nieuwpoort, L.I. Arwert, M.W. Heymans, A.A.M. Franken, H.P.F. Koppeschaar, A.J. van der Lely, M.L. Drent | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P235 | HORMONAL EFFECTS ON CARDIOVASCULAR FUNCTION IN PATIENTS WITH ACROMEGALY | Myroslava Mykytyuk, Oksana Khyzhnyak, Tatyana Sulima, Yuri Karachentsev | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P236 | Expression of Canonical Wnt proteins and Survivin in Pituitary Tumours | R Formosa, M Grupetta, S Falzon, G Santillo, J DeGaetano, A Xuereb-Anastasi, J Vassallo | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P237 | Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly. | M.R. Postma, R.T. Netea-Maier, G. van den Berg, J. Homan, W.J. Sluiter, A.C.M. van den Bergh, B.H.R. Wolffenbuttel, A.R.M.M. Hermus, A.P. van Beek | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P238 | Improvement of acromegalic cardiomyopathy following pituitary apoplexy | Guillermo Serra Soler, Elena Mena Ribas, Jaume Pons Llinares, Pere Pericàs Ramis, Sergio Díaz Medina, Bárbara Manga Perla y Perla, Iñaki Argüelles Jiménez, Santiago Tofé Povedano, Mercedes Codina Marcet, Honorato García Fernández, Vicente Pereg Macazaga | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P239 | Pituitary apoplexy as initial manifestation of pituitary tumors: two case reports | J Saraiva, L Gomes, I Paiva, J Santos, A Vieira, M Alves, S Gouveia, M Carvalheiro | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P240 | Detection of antipituitary antibodies using human and primate pituitary glands in patients with autoimmune thyroid disease and diabetes mellitus type 1. | Libuse Srbova, Hadzi Nikolov, Jan Cap | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P241 | Periodontal disease ferquency in acromegalic patients | Sibel Bascil, Hülya Serinsöz, Eda Ertörer, Neslihan B Tutuncu | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P242 | Relationship between growth hormone activity and markers of inflammation - a cross-over study of healthy volunteers treated with growth hormone and a growth hormone antagonist for three weeks | M Andreassen, J Frystyk, J Faber, LØ Kristensen | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P243 | DIABETES MELLITUS AS ADJUNCTIVE RISK FACTOR FOR VERTEBRAL FRACTURES IN MEN WITH ACROMEGALY | G Mazziotti, A Bianchi, M Gola, T Porcelli, L De Marinis, A Giustina | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P244 | HYPERPROLACTINEMIA IS A RISK FACTOR FOR RADIOLOGICAL VERTEBRAL FRACTURES IN POST-MENOPAUSAL WOMEN. | G Mazziotti, T Mancini, M Mormando, E De Menis, A Bianchi, M Doga, L De Marinis, A Giustina | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P245 | Efficacy of weekly pegvisomant monotherapy | RD O'Connor, AJ van der Lely, M Madsen, JO Jorgenson, SJCMM Neggers | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P246 | AcroBel-2: the Belgian follow-up survey on acromegaly: contribution of pituitary surgery and the use of pegvisomant to an improvement in disease control. | M Bex, R Abs, G T'Sjoen, B Corvilain, B Velkeniers, D Maiter | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P247 | A MULTICENTER STUDY ON ACROMEGALIC PATIENTS TREATED WITH PEGVISOMANT MONOTHERAPY OR WITH PEGVISOMANT PLUS SOMATOSTATIN ANALOGUES: ROLE OF EXON 3 DELETED GH RECEPTOR POLYMORFISM A MULTICENTER STUDY ON ACROMEGALIC PATIENTS TREATED WITH PEGVISOMANT MONOTHERAPY OR WITH PEGVISOMANT PLUS SOMATOSTATIN ANALOGUES: ROLE OF EXON 3 DELETED GH RECEPTOR POLYMORFISM | Marcello Filopanti, Luca Olgiati, Andrea Lania, Paolo Beck-Peccoz, Laura De Marinis, Silvia Grottoli, Chiara Martini, Salvatore Cannavò, Fausto Bogazzi, Diego Ferone, Giorgio Arnaldi, Alessandro Peri, Patrizia Tita, Francesca Pigliaru, Gabriella Angeletti, Marie-Lise Jaffrain-Rea, Marco Losa, Anna Spada | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P248 | Detection of acromegaly by automatic face classification software | HJ Schneider, R Kosilek, M Günther, J Römmler, GK Stalla, C Sievers, M Reincke, J Schopohl, R Würtz | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P249 | Prolactinoma cell culture – experimental model for tumor growth | D. Manda, O. Popa, S. Vladoiu, C. Stancu, A. Serban, M. Coculescu, O. Ianas | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P250 | Evolution of invasive treatment-resistant prolactin (PRL) adenoma. | M. Vetri, P. Tita | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P251 | Lost to follow-up in acromegaly, results of ACROSPECT observational study | BD Delemer, CR Reines, TB Brue, CC Cortet Rudelli, IR Raingeard, YR Reznik, XP Parot, OC Chabre | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P252 | Initial management and complications of Cushing disease (CD) : a French multicenter study of 437 patients. | C. Baudry, M. Martinie, M. Fathallah-Sahnoun, B. Gatta-Cherifi, R. Bou Khalil, L. Guignat, E. Gay, G. Raverot, T. Brue, A. Tabarin, O. Chabre, J. Bertherat | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P253 | The value of T2 weighted MR-imaging for stratification to medical therapy in newly diagnosed acromegaly | A. Heck, G. Ringstad, O Casar-Borota, S.L. Fougner, J. Hald, J. Ramm-Pettersen, J. Bollerslev | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P254 | Lack of efficacy of 24-month treatment with the GH receptor antagonist pegvisomant in patient with active acromegaly resistant to long-term, high-dose somatostatin analog treatment: effects on IGF-1 and GH levels. | M. Vetri, P. Tita | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P255 | Quality of life and cortisol diurnal rhythm after three months of medical treatment for Cushing’s disease | R van der Pas, C de Bruin, A Pereira, J Romijn, R Netea, A Hermus, P Zelissen, F de Jong, A van der Lelij, W. de Herder, S Webb, S Lamberts, L Hofland, R Feelders | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P256 | Low incidence of adrenal insufficiency after transsphenoidal surgery in patients with acromegaly: a long-term follow-up study | A.M.G. Burgers, N.E. Kokshoorn, A.M. Pereira, F Roelfsema, J.W.A. Smit, N.R. Biermasz, J.A. Romijn | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P257 | FERTILITY RATE IN ACROMEGALIC WOMEN: A SINGLE CENTER EXPERIENCE ON 70 PATIENTS BEFORE AND AFTER TREATMENT | L.F.S. GRASSO, M. GALDIERO, R.S. AURIEMMA, A. COZZOLINO, P. VITALE, C. SIMEOLI, R. PIVONELLO, A. COLAO | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P258 | Prevalence of germline mutations of AIP gene in sporadic aggressive somatotropinomas | M Puig-Domingo, J Oriola, I Halperin, M Mora, G Diaz-Soto, MJ Perales, C Alvarez-Escolá, T Lucas-Morante, Ignacio Bernabeu, Mónica Marazuela | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P259 | PREDICTIVE MARKERS OF RECURRENCE IN RADICALLY RESECTED PITUITARY MACROADENOMAS | L. Curtò, R. M. Ruggeri, O. R. Cotta, M. Ragonese, A. Ieni, S. Puglisi, D. Costanzo, F. Trimarchi, Salvatore Cannavò | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P260 | Mechanism and management of hyperglycemia associated with pasireotide: results from studies in healthy volunteers | RR Henry, S Mudaliar, K Wetli-Hermosillo, M Ligueros-Saylan, S Chenji, G Golor | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P261 | The efficacy of octreotide LAR in acromegalic patients | Zelija Velija-Asimi | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P262 | A NOVEL AIP MUTATION RELATED TO FAMILIAL ISOLATED PITUITARY ADENOMAS (FIPA). | I Bilbao Garay, M Alvarez Coca, A Daly, A Beckers, M Goena | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P263 | Octreotide Pharmacokinetics and Biochemical Control of Acromegaly Using a Subcutaneous Octreotide Hydrogel Implant | C. Chieffo, M. Ryan, S. Bai, X. Hu, S. Decker, H. Quandt, L. Frohman, M. Gadelha | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P264 | Transition to endoscopic transsphenoidal pituitary surgery: a single-center experience | W Billmann, S Bilz, A von Hessling, A.J. Tasman, M Brändle, G Hildebrandt, J.Y. Fournier | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P265 | Pasireotide (SOM230) demonstrates efficacy in patients with Cushing’s disease: results from a large, randomized-dose, double-blind, Phase III study | A Colao, S Petersenn, J Newell-Price, JW Findling, F Gu, M Maldonado, U Schoenherr, D Mills, LR Salgado, BMK Biller | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P266 | Clonality analysis of pituitary adenomas – a pilot study | I Baciu, S Radian, C Capatina, I Botusan, D Aflorei, L Tataranu, V Ciubotaru, M Coculescu | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P267 | Effect Of Gender And On The Invasiveness Of Prolactinomas | S Cander, E Ertürk, Ö Öz Gül, OK Ünal, S Imamoglu | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P268 | Frequency of acute-onset symptoms and other features of craniopharyngioma presentation in children and adults | E. H. Nielsen, J. O. Jørgensen, P. Bjerre, M. Andersen, C. Andersen, U. Feldt-Rasmussen, L. Poulsgaard, L. Ø. Kristensen, Jens Astrup, Jörgen Lindholm, Peter Laurberg | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P269 | Macroprolactinomas and pregnancy: analysis of a 38-women cohort treated by dopamine agonists. | B Decoudier, G Raverot, D Ancelle, AC Hécart, F Borson-Chazot, B Delemer | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P270 | PRIMARY EMPTY SELLA IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK, REGARDLESS THE OCCURRENCE OF PITUITARY DYSFUNCTION | M. L. Torre, O. R. Cotta, F. Ferrau', E. Di Mauro, A. Albani, M. Boschetti, C. Teti, M. C. Savanelli, C. Di Somma, A. Alibrandi, D. Ferone, S. Cannavo', A. Colao | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P271 | Evaluation of health-related quality of life in patients with Cushing’s disease and patients with non-functioning pituitary adenomas | Christina Dimopoulou, Hildegard Pfister, Jochen Schopohl, Guenter Karl Stalla, Caroline Sievers | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P272 | Topoisomerase II alpha expression in human pituitary adenomas as the prognostic factor | M Trofimiuk, G Sokolowski, F Golkowski, D Adamek, A Hubalewska-Dydejczyk | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P273 | Cyclooxygenase 2 expression in human pituitary adenomas | G Sokolowski, M Trofimiuk, F Golkowski, D Adamek, A Hubalewska-Dydejczyk | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P274 | RECENT CHANGES IN CLINICAL PRESENTATION AND THERAPEUTIC APPROACH IN MEN1-RELATED PITUITARY ADENOMAS | Valeria Ramundo, Rosa Severino, Francesco Milone, Gaetano Lombardi, Annamaria Colao, Antongiulio Faggiano | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P275 | PROLACTINOMA AND THYROID FUNCTION | I. Kostoglou-Athanassiou, S. Tagara, A. Michou, E. Xanthakou, A. Chronaiou, S. Kotanoglou, K. Tzioras, A. Karfi | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P276 | LATE DEVELOPMENT OF RESISTANCE TO CABERGOLINE IN A GIANT MACROPROLACTINOMA WITH AGGRESSIVE CARVENOUS SINUS AND SPHEINODAL BONE INVASION | G Mlawa, S Deshmukh, A Nasruddin, D Sandeman | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P277 | Minimal Active Acromegaly may be effectively treated by prolonged injections of octreotide LAR. | P Zdunowski, W Zgliczyński | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P278 | Radiological features of breast benign lesions in patients with hyperprolactinemia | D. Radojkovic, M. Pesic, S. Antic, S. Radenkovic, S. Kostic, V. Ciric | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P279 | A patient with ACTH-dependent Cushing’s syndrome and an unexpected neuropathogical diagnosis | I Kreitschmann-Andermahr, FJ Hans, M Mull, W Karges, K Nolte | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P280 | Immunoglobulin G4-related infundibulo-hypophysitis: report of 4 cases and review of the literature | A Shimatsu, K Nanba, Y Oki, T Tagami, T Usui, M Naruse | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P281 | Assessment of Retinopathy in Acromegaly | C Anil, C Demir, G Simsek Bagir, S Sizmaz, O Bakiner, ME Ertorer, D Altinors, A Nar, Neslihan Bascil Tutuncu | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P282 | Success Rate Of Surgery In Patients With Macroprolactinoma | E Ertürk, OK Unal, S Cander, Ö Öz Gül, M Özdemir Oruc, I Esen, S Imamoglu | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P283 | GROWTH HORMONE DEFICIENCY IN CURED ACROMEGALIC PATIENTS: METABOLIC EFFECTS OF RECOMBINANT hGH REPLACEMENT. | C Giavoli, E Verrua, E Ferrante, CL Ronchi, E Profka, M Arosio, A Spada, P Beck-Peccoz | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P284 | Improvement in clinical signs and symptoms of Cushing’s disease following 12 months’ pasireotide therapy | R Pivonello, J Newell-Price, JW Findling, F Gu, M Maldonado, U Schoenherr, D Mills, LR Salgado, BMK Biller | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P285 | Pituitary calf transplantation into the human, 50 years after | K Marczewski, M Gasiorek, M Maciejewski, J Wszola-Kleinrok | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P286 | The impact of transsphenoidal surgery on glucose homeostasis and insulin resistance in acromegaly. | Maria Stelmachowska-Banas, Grzegorz Zielinski, Piotr Zdunowski, Jan Podgorski, Wojciech Zgliczynski | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P287 | TUMOR SIZE AND PARASELLAR EXTENSION INFLUENCE ON MACROPROLACTINOMAS’ OUTCOME | R.A. Trifanescu, V. Mihaila, A. Serban, D. Hortopan, A. Dumitrascu, A. Caragheorgheopol, M. Coculescu | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P288 | Pegvisomant therapy in acromegaly: a multicenter observational study | A Bianchi, L Tilaro, F Valentini, P Gargiulo, M Poggi, R Baldelli, M Passeri, L De Marinis | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P289 | ACTH-SECRETING PITUITARY ADENOMAS EXPRESS HIGHER SSTR5 THAN SSTR2 PROTEIN LEVELS BY IMMUNOHISTOCHENISTRY USING NEW MONOCLONAL ANTIBODIES AGAINST SST-BINDING DOMAINS | V Rossi, G Bellastella, S Staibano, G Ilardi, ML Del Basso De Caro, L Cavallo, P Cappabianca, C Abbondanza, A Colao, A Bellastella, AA Sinisi | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P290 | Cardiac Risk in Patients with Treatment Naïve, First-Line Medically Controlled and First-Line Surgically Cured Acromegaly in Comparison to Matched Data from the General Population | Christian Berg, Stephan Petersenn, Burkhard Herrmann, Ulla Roggenbuck, Nils Lehmann, Susanne Moebus, Karl-Heinz Jöckel, Stefan Moehlenkamp, Raimund Erbel, Klaus Mann | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P291 | Growth Hormone Receptor mRNA expression and the effect of Pegvisomant on Growth Hormone secretion by Somatotroph Pituitary adenomas | S.J.C.M.M. Neggers, M. Bidlingmaier, P.M. van Koetsveld, R.A. Feelders, D.M. Sprij-Mooij, W.W. de Herder, AJ. van der Lely, L.J. Hofland | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P292 | CAROTENOIDS INHIBITS CELL PROLIFERATION, ARREST CELL CYCLE AND INDUCES APOPTOSIS IN PITUITARY TUMOR CELLS | Natalia Haddad, Anderson Junger Tedoro, Nathalia da Costa Pereira Soares, Felipe Leite Oliveira, Radovan Borojevic, Luiz Eurico Nasciutti, Leandro Miranda Alves | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P293 | Prevalence of sleep apnea sindrome (SAS) in patients with acromegaly | DANIELA AMZAR, STEFAN MIHAICUTA, IOANA GOLU, MELANIA BALAS, MIHAELA VLAD | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P294 | Patients previously treated for nonfunctioning pituitary macroadenomas have disturbed sleep characteristics, circadian movement rhythm, and subjective sleep quality. | S.D Joustra, N.R. Biermasz, E. Donga, A.M. Pereira, N Van Duinen, M VAn Dijk, A.A. Van der Klaauw, E.P.M. Corssmit, Gert Jan Lammers, Klass Van Kralingen, J.G. Van Dijk, J. A. Romijn | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P295 | The dual PI3K/mTOR inhibitor NVP-BEZ235 has a potent antiproliferative action in human nonfunctioning pituitary adenomas. | V Cerovac, M Tichomirowa, G Stalla, M Theodoropoulou | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P296 | PRIMARY PITUITARY TUMORS. TEN YEAR SINGLE CENTER EXPERIENCE | A. Gkountouvas, I. Kostoglou-Athanassiou, M. Nikas, F. Chatzimarkou, I. Keramidas, D. Thomas, P. Georgiadis, P. Kaldrymidis | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P297 | Pituitary apoplexy – clinical characteristics, circumstances of diagnosis and evolution in a Romanian patient series | ML Gheorghiu, C Badiu, D Hortopan, A Dumitrascu, A Caragheorgheopol, D Alexandrescu, M Coculescu | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P298 | EFFECTS OF SHORT (6 MONTHS) AND LONG (18 MONTHS) TERM TREATMENT WITH GH-RECEPTOR ANTAGONIST PEGVISOMANT (PEG) ON RHYTHM DISTURBANCES IN ACROMEGALY. | Renata Simona Auriemma, Rosario Pivonello, Maria Cristina De Martino, Giuseppe Cudemo, Mariano Galdiero, Ludovica F.S. Grasso, Chiara Simeoli, Annamaria Colao | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P299 | Pituitary dysfunction types and clinical presentation of pituitary microadenomas in childhood and adolescence | L Saranac, B Bjalakovic, S Zivanovic, M Novak, I Markovic, Z Radovanovic | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P300 | Secondary erythrocytosis due to acromegaly. | E Pigarova, E Dobracheva, L Dzeranova, L Rozhinskaya | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P301 | Patients with active acromegaly (AA) have less hepatic triglyceride than normal subjects using Proton Magnetic Resonance Spectroscopy (1H MRS) | Stephen McGlynn, Tim Morris, Claire Higham, Steve Williams, Peter Trainer | 16. Pituitary (to include prolactin, acromegaly, pituitary tumours) |
| P302 | OBESITY IN GDM | Luisa Ruas, Marcia Alves, Sandra Paiva, Elvira Marta, António Lobo, Paulo Moura, Manuela Carvalheiro | 17. Obesity |
| P303 | OBESITY, METABOLIC SYNDROME, HEPATIC STEATOSIS, FIBROSIS AND VIRAL LOAD AS NEGATIVE FACTORS AFFECTING EARLY (EVR) AND SUSTAINED (SVR) VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGINTERFERON AND RIBAVIRIN | M Tataru Abagiu, EF Georgescu, R Teodorescu, L Stanescu | 17. Obesity |
| P304 | Insulin resistance and some coagulation and fibrinolytic parameters in subjects with metabolic syndrome | Nashwa Abousamra, Amany Ragab, Omayma Saleh, Asmaa Higazy | 17. Obesity |
| P305 | Testosterone therapy increased muscle mass and lipid oxidation in ageing men | L Frederiksen, K Højlund, DM Hougard, K Brixen, M Andersen | 17. Obesity |
| P306 | Development and characterization of high-affinity leptins and leptin antagonists | M Shpilman, L Niv-Spector, M Katz, C Varol, G Solomon, E Elinav, A Gertler | 17. Obesity |
| P307 | Ghrelin effects on nutrition and digestion in pest insects | V. Perić Mataruga, M. Mrdaković, B. Janać, M. Vlahović, D. Mirčić, L. Ilijin, V. Milošević | 17. Obesity |
| P308 | TNFα plays an essential role in the downregulation of sex hormone-binding globulin production by decreasing hepatic HNF-4α through NF-κB activation | A Barbosa-Desongles, R Simo, A Lecube, C Hernandez, D Selva | 17. Obesity |
| P309 | Benzofran derivatives inhibit 11beta-hydroxysteroid dehydrogenase type 1 in rodent adipose tissue | Y Kobayashi, K Daisuke, Y Yamaguchi, M Ueda, O Miyata, N Tagawa | 17. Obesity |
| P310 | Effect of dehydroepiandrosterone on 11beta-hydroxysteroid dehydrogenase type 1 in rodent adipocytes | N Tagawa, E Minamitani, D Kiyonaga, Y Kobayashi | 17. Obesity |
| P311 | Waist circumference is a better predictor of cardiovascular risk than body mass index in patients with type 2 diabetes mellitus | F.J. del Cañizo-Gómez, I. Moreno-Ruíz, A. Segura-Galindo, C. de Gorospe, T. González-Losada, B. Silveira Rodríguez | 17. Obesity |
| P312 | EFFECTS OF NATURAL DIETARY ANTIOXIDANTS ON INSULIN AND IGF-1 IN OBESE PATIENTS WITH INSULIN RESISTANCE | A. MANCINI, M. MAGINI, R. FESTA, S. RAIMONDO, A. SILVESTRINI, A. PONTECORVI, E. MEUCCI, G.E. MARTORANA | 17. Obesity |
| P313 | ENVIROMETAL AND METABOLIC RISK FACTORS OF OBESITY DEVELOPMENT IN PRESCHOOL CHILDREN | L. S. Viazava, A. V. Solntsava, A. V. Sukalo, E. I. Dashkevich | 17. Obesity |
| P314 | GENDER DIFFERENCES OF LEPTIN RECEPTOR GENE GENOTYPES AND LEPTIN LEVELS IN OBESE CHILDREN | A.V. Solntsava, E.A. Aksionava, N.G. Danilenko, L.S. Viazava, A.V. Sukalo | 17. Obesity |
| P315 | Testosterone and metabolic syndrome: a meta-analysis study | Giovanni Corona, Matteo Monami, Giulia Rastrelli, Antonio Abersa, Yuliya Tishova, Farid Saad, Andrea Lenzi, Gianni Forti, Mario Maggi | 17. Obesity |
| P316 | Identification of a reliable biomarker for Metabolic Syndrome | A.R Abdullah, H Hasan, V Raigangar | 17. Obesity |
| P317 | SERUM VITAMIN D and IGF-1 LEVELS IN ABDOMINAL OBESITY WOMEN | T. Karonova, O. Belyaeva, E. Bazhenova, D. Azzi, A. Berezina, N. Katysheva, O. Galkina, E. Micheeva, E. Grineva | 17. Obesity |
| P318 | SERUM ADIPONECTIN LEVELS IN PATIENTS WITH TYPE 1 GAUCHER DISEASE | S Petakov, N Suvajdzic, S Ognjanovic, T Isailovic, D Macut, M Djurovic, I Bozic, S Damjanovic | 17. Obesity |
| P319 | Undiagnosed thyroid dysfunction, leptin and body mass index | I Olaizola, ML Granada, MT Julián, C Castell, A Serra, A Alastrué, A Lucas | 17. Obesity |
| P320 | Low birth weight and obesity are associated with increased androgen levels among children with premature adrenarche | L LEKKA, E KOUSTA, K ANYFANDAKIS, S LEKA, A PAPATHANASSIOU | 17. Obesity |
| P321 | Prevalence of metabolic syndrome in 850 obese children from infancy to adolescence. | S Bellone, F Prodam, R Ricotti, A Petri, V Agarla, C Guidi, G Genoni, G Bona | 17. Obesity |
| P322 | The effect of androgens on adipose tissue in PCOS | M. 't Mannetje, E. L. A. F. van Houten, A. McLuskey, P. Kramer, A. P.N. Themmen, J. A. Visser | 17. Obesity |
| P323 | FUNCTIONAL DIFFERENCES BETWEEN VISCERAL AND SUBCUTANEOUS FAT PADS ORIGINATE IN THE ADIPOSE STEM CELL | G Cantini, S Baglioni, M Francalanci, G Poli, E Borgogni, A Di Franco, R Squecco, F Francini, M Lucchese, G Perigli, M Serio, M Luconi | 17. Obesity |
| P324 | Basal energy expenditure and fat mass changes in breast cancer patients | Nermin Tuncbilek, Sibel Güldiken, Neslihan Soysal Atile, Betül Ekiz Bilir, Deniz Köken | 17. Obesity |
| P325 | Waist line radius to subcutaneous adipose tissue thickness- better insight to lipid stores centralisation | P Ristic, D Bokunjic, Z Andjelkovic | 17. Obesity |
| P326 | Serum leptin level and its association with body composition in obese children | M Vishnevskaya, A Solnceva | 17. Obesity |
| P327 | Inflammatory T-lymphocyte proliferation in morbid obesity | K. van der Weerd, W.A. Dik, B. Schrijver, D.H. Schweitzer, A.W. Langerak, R.M. Kiewiet, M.O. van Aken, J.J.M. van Dongen, A.J. van der Lelij, F.J.T. Staal, P.M. van Hagen | 17. Obesity |
| P328 | Letrozole normalizes serum testosterone but has no clinical effects in men with obesity-related hypogonadotropic hypogonadism | S Loves, J de Jong, A van Sorge, D Telting, A Hermus, H de Boer | 17. Obesity |
| P329 | Small animal PET/CT imaging reveals altered in vivo insulin function in brown adipose tissue of obese mice | C Quarta, M Bucci, M Colavita, S Fanti, S Obici, R Pasquali, P Iozzo, U Pagotto | 17. Obesity |
| P330 | Haematic circulating endocannabinoids (ECs) in lean, overweight and obese: the role of the gender | F Fanelli, VD Di Lallo, I Belluomo, E Casadio, M Baccini, D Ibarra Gasparini, V Vicennati, R Pasquali, Uberto Pagotto | 17. Obesity |
| P331 | Enhanced muscle mass by ALA treatment increase myostatin-mediated pathways in adipose tissue | HS Kwon, OK HONG, SS LEE, SR KIM, SJ YOO | 17. Obesity |
| P332 | Effects of food, hormones and autonomic nervous activity on rhythmic expression of clock genes and metabolic genes in rat white adipose tissue. | R van der Spek, L Kervezee, S La Fleur, E Fliers, A Kalsbeek | 17. Obesity |
| P333 | Investigating the Role of FTO in Obesity: Dysregulation of Satiety Signalling | F McMurray, C Church, R D Cox | 17. Obesity |
| P334 | Synergistic post-prandial deregulation of orexigenic and anorexigenic systems in obesity | B Gatta-Cherifi, I Mattias, M Vallée, A Tabarin, G Marsicano, P.V Piazza, D Cota | 17. Obesity |
| P335 | LONG-TERM EFFECTS OF NORMALIZATION OF TESTOSTERONE ON VARIABLES OF THE METABOLIC SYNDROME IN HYPOGONADAL MEN: THE MOSCOW STUDY | L.J. Gooren, S.Y. Kalinchenko, Y.A. Tishova, G.J. Mskhalaya, E.J. Giltay, F. Saad | 17. Obesity |
| P336 | THERAPY WITH EXENATIDE IN OBESE AND MORBIDLY OBESE TYPE 2 DIABETIC PATIENTS: COMPARATIVE ANALYSIS | M Diéguez Felechosa, C Tusón Rovira, C Sánchez Ragnarsson, F Casal Alvarez, N Valdés Gallego, L Manjón Miguélez, J Prieto Santiago | 17. Obesity |
| P337 | VITAMIN D AND OBESITY | I. Kostoglou-Athanassiou, A. Chronaiou, V. Trianti, S. Tagara, A. Michou, A. Liakopoulou, T. Terzi, A. Karfi | 17. Obesity |
| P338 | Glimepiride improves insulin sensitivity In oxidative skeletal muscle of obese rats: possible association between GLUT4 and SUR2A expressions | M.F.S.F.M Felipe dos Santos Ferreira Marques, R.C.T.M Cristina Tieko Mori, M.M.O Mitiko Okamoto, U.F.M Fabres Machado | 17. Obesity |
| P339 | Τhe relationship between adiposity and carbohydrate metabolism, by age and gender in Vlora, a city in Albania. | Yllka Bilushi, Glodiana Sinani, Llukan Rrumbullaku | 17. Obesity |
| P340 | Long term low intensity recreational physical exercise attenuates colonic inflammation in rats: the role of heme oxygenase system | Z Szalai, AM Berkó, A Pósa, R Szabó, K Orbán, A Király, F László, Cs Varga | 17. Obesity |
| P341 | EFFECTS OF OREXIN-A ON AMPK ACTIVITY | A.H. Molnár, G.K. Kis, C. Varga, K. Rákosi, M. Scerif, F.A. László, F. László, M. Korbonits | 17. Obesity |
| P342 | MONITORING THE EFFICACY OF LONG TERM LOW INTENSITY PHYSICAL EXERCISE PROGRAMMES BY THE LABORATORY AND HORMONE PROFILE OF OBESITY | AM Berkó, GK Kis, P Szablics, B Kiss, K Orbán, E Seres, Cs Varga, F László | 17. Obesity |
| P343 | 3-iodothyronamine metabolism and metabolic effects in rat white adipocytes. | M.E. Manni, E. Bigagli, A. Saba, M. Marchini, R. Zucchi, L. Raimondi | 17. Obesity |
| P344 | The Modulation of Brain Derived Neurotrophic Factor (BDNF) during Exercise in Obesity | A. M. Arafat, A. Brunelli, H. Budde, A. Adamidou, J. Spranger, M. Möhlig, A.F.H. Pfeiffer | 17. Obesity |
| P345 | The Modulation of Atrial Natriuretic Peptide Levels during Exercise in Obesity | A. Adamidou, M. Möhlig, A.F.H. Pfeiffer, A. M. Arafat | 17. Obesity |
| P346 | AM251, a CB1 receptor antagonist, increases GLUT4 expression in adipocytes. | D T Furuya, A C Poletto, H S Freitas, U F Machado | 17. Obesity |
| P347 | SERUM HOMOCYSTEINE LEVELS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE | SA Polyzos, J Kountouras, K Patsiaoura, E Katsiki, E Zafeiriadou, G Deretzi, C Zavos, E Gavalas, V Mane, A Slavakis | 17. Obesity |
| P348 | BODY MASS INDEX, OBESITY AND HYPERURICEMIA IN POSTMENOPAUSAL WOMEN | V Povoroznyuk, G Dubetska | 17. Obesity |
| P349 | Beneficial effects of testosterone supplementation on prostatitis-like alterations in an animal model of metabolic syndrome. | A Morelli, S Filippi, L Vignozzi, P Comeglio, E Sarchielli, E Maneschi, I Cellai, GB Vannelli, M Maggi | 18. Steroid metabolism + action |
| P350 | Testosterone supplementation improves adipose tissue function in an animal model of metabolic syndrome. | A Morelli, E Maneschi, L Vignozzi, S Filippi, M Marchetta, B Mazzanti, A Calcagno, P Comeglio, I Cellai, GB Vannelli, M Maggi | 18. Steroid metabolism + action |
| P351 | Evaluation of a method to measure long term cortisol levels in health and disease | L Manenschijn, J.W. Koper, E.L.T. van den Akker, R.A. Feelders, S.W.J. Lamberts, E.F.C. van Rossum | 18. Steroid metabolism + action |
| P352 | Effect of smoking cessation on steroid balance in postmenopausal women | Hana Hruskovicova, Michaela Duskova, Katerina Simunkova, Martin Hill, Hana Pospisilova, Eva Kralikova, Karel Vondra, Luboslav Starka | 18. Steroid metabolism + action |
| P353 | Activin A regulates local testosterone production and growth in prostate cancer through 17beta-hydroxysteroid dehydrogenase | J Hofland, WM van Weerden, J Steenbergen, NFJ Dits, G Jenster, FH de Jong | 18. Steroid metabolism + action |
| P354 | Standardized High Throughput LC-MS/MS Steroid-Quantification for Clinical Metabolomics | Therese Koal, Diane Schmiederer, Hai Pham Tuan, Cornelia Röhring, Manfred Rauh | 18. Steroid metabolism + action |
| P355 | Salivary cortisol and testosterone: a comparison of salivary sample collection methods in healthy controls | E Van Caenegem, K Wierckx, T Fiers, H Segers, E Vandersypt, JM Kaufman, G T'Sjoen | 18. Steroid metabolism + action |
| P356 | HORMONAL PARAMETERS AND SEX HORMONE RECEPTOR GENE POLYMORPHISMS IN MALES WITH AUTOIMMUNE DISEASES | Charalampos Doukas, Katerina Saltiki, Kostas Terzidis, Aimily Mantzou, Lida Sarika, Andriana Cimponeriu, Petros Sfikakis, Maria Alevizaki | 18. Steroid metabolism + action |
| P357 | Inhibitory effect of glucocorticoids on GLUT4 expression in visceral adipose tissue may be determined by increased 11β hydroxysteroid dehydrogenase 1 (11β-HSD1) expression. | RCT Mori, RS Campello, UF Machado | 18. Steroid metabolism + action |
| P358 | Chronic effect of 17β estradiol on GLUT4 expression in 3T3-L1 adipocytes | RS Campello, AC Poletto, DT Furuya, RCT Mori, UF Machado | 18. Steroid metabolism + action |
| P359 | Oleic and Linoleic fatty acids reduce the SLC2A4 gene expression: the involvement of the NFkappaB and HIF-1a transcriptional factors. | A C Poletto, D T Furuya, R A dos Santos, G F Anhê, A D Silva, R S Campello, U F Machado | 19. Nuclear receptors |
| P360 | PHEOCHROMOCYTOMA: A COMPLEX CASE | F Fonseca, A Cordero, J Oliveira, L Mourão, J Coutinho, A Agapito | 2. Adrenal medulla (to include pheochromocytoma and paraganglioma) |
| P361 | Head and Neck Paragangliomas: genetic spectrum and clinical variability in 101 consecutive patients. | Valentina Piccini, Elena Rapizzi, Alessandra Bacca, Giuseppe Di Trapani, Raffaele Pulli, Valentino Giachè, Benedetta Zampetti, Letizia Canu, Antongiulio Faggiano, Luca Deiana, Stefano Mariotti, Maria Rosaria Ambrosio, Maria Chiara Zatelli, Gabriele Parenti, Annamaria Colao, Carlo Pratesi, Gianpaolo Bernini, Tonino Ercolino, Massimo Mannelli | 2. Adrenal medulla (to include pheochromocytoma and paraganglioma) |
| P362 | SUCCINATE DEHYDROGENASE (SDH) MUTATIONS: BIOCHEMICAL AND FUNCTIONAL EFFECTS IN PHEOCHROMOCYTOMA/PARAGANGLIOMA TISSUES | E Rapizzi, T Ercolino, L Canu, V Giachè, M Mannelli | 2. Adrenal medulla (to include pheochromocytoma and paraganglioma) |
| P363 | Expression of IGF/mTOR pathway components in human pheochromocytomas and in vitro inhibition of PC12 rat pheochromocytoma cell growth by mTOR inhibitors | MC De Martino, RA Feelders, PM van Koetsveld, RR De Krijger, JAMJL Janssen, D Sprij-Mooij, SWJ Lamberts, WW de Herder, Annamaria Colao, Rosario Pivonello, Leo Hofland | 2. Adrenal medulla (to include pheochromocytoma and paraganglioma) |
| P364 | Unusual mutation spectrum in Hungarian patients with apparently sporadic pheochromocytomas | NL Lendvai, IS Szabó, MT Tóth, EF Fórizs, ES Sólyom, GB Beko, PI Igaz, KR Racz, AP Patocs | 2. Adrenal medulla (to include pheochromocytoma and paraganglioma) |
| P365 | Pheochromocytoma occurs in Saudi patients with multiple endocrine neoplasia type 2A (MEN 2A) | Tariq Nasser, Abdullah Karawagh, Faiza Qari | 2. Adrenal medulla (to include pheochromocytoma and paraganglioma) |
| P366 | Impact of surgery upon lipid profile in a case series of pheochromocytoma | Corin Badiu, Simona Jercalau, Vadim Gavan, Ruxandra Dobrescu, Victor Tomulescu, Mircea Beuran, Ana Maria Stefanescu | 2. Adrenal medulla (to include pheochromocytoma and paraganglioma) |
| P367 | Transmenbrane potential (ΔΨр) slight changes in non-excitable individual cells at short-term hormone action Kavok NS, Malyukina MYu, Borovoy IA, Pogrebniak NL Institute for Scintillation Materials NAS of Ukraine 60 Lenin ave., 61001 Kharkov, Ukraine | NS Kavok, MYu Malyukina, IA Borovoy, NL Pogrebniak | 20. Signal transduction |
| P368 | Research resource for analysing functional data of Glycoprotein Hormone Receptors: Novel tools to gain deeper insights into molecular mechanisms | A Kreuchwig, G Kleinau, F Kreuchwig, CL Worth, G Krause | 20. Signal transduction |
| P369 | Different and common transmembrane activation mechanisms between glycoprotein hormone receptors and other G-protein coupled receptors | I Hoyer, G Kleinau, AK Haas, A Kreuchwig, P Grzesik, CL Worth, R Schuelein, G Krause | 20. Signal transduction |
| P370 | Distribution of 3-iodothyronamine and trace amine-associated receptors in mouse. | G. Chiellini, P. Erba, V. Carnicelli, S. Ghelardoni, S. Frascarelli, R. Zucchi | 20. Signal transduction |
| P371 | MINIMALLY INVASIVE VIDEO-ASSISTED THYROIDECTOMY VERSUS CONVENTIONAL THYROIDECTOMY: A SINGLE-BLINDED, RANDOMIZED CONTROLLED CLINICAL TRIAL | GOUDA ELLABBAN | 21. Thyroid (non-cancer) |
| P372 | Complications after Thyroidectomy: a 10 years experience in a District General Hospital | S Jafferbhoy, N.I Ramus | 21. Thyroid (non-cancer) |
| P373 | Risk factors for morbidity after Thyroid Surgery: analysis of 559 cases | S Jafferbhoy, N.I Ramus, S Ilyas | 21. Thyroid (non-cancer) |
| P374 | Acoustic Radiation Force Impulse Imaging of thyroid gland | M Friedrich-Rust, O Romenski, G Meyer, N Dauth, K Holzer, F Gruenwald, S Zeuzem, J Bojunga | 21. Thyroid (non-cancer) |
| P375 | The influence of cure of subclinical hyperthyroidism on left ventricular walls thickness and mass index | G. Kaminski, K. Makowski, M. Ruchala, E. Szczepanek, T. Bednarczuk | 21. Thyroid (non-cancer) |
| P376 | THE USE OF LITHIUM AND PERCHLORATE THERAPY IN SPECIAL CASES OF HYPERTHYROIDISM | I.Z. Kun, Zs. Szanto, T. Bartok, C.C. Pop Radu, I. Pascanu | 21. Thyroid (non-cancer) |
| P378 | SELENIUM TREATMENT IN CHRONIC AUTOIMMUNE THYROID DISEASES | I.Z. Kun, Zs. Szanto, I. Kun | 21. Thyroid (non-cancer) |
| P380 | A CASE of RIEDEL’S THYROIDITIS | Tufan Elipek, Bülent Bilir, Betül Ekiz Bilir, Sibel Güldiken, Semsi Altaner | 21. Thyroid (non-cancer) |
| P381 | Molecular analysis and functional significance of TSHR gene mutations in pediatric patients | Stefania Moia, Flavia Prodam, Alice Monzani, Simonetta Bellone, Stefania Riccomagno, Gillian Walker, Letizia Trovato, Marta Roccio, Patrizia Agretti, Gianni Bona | 21. Thyroid (non-cancer) |
| P382 | Evolution of thyroid function and antibodies in Hashimoto thyroiditis after 10 years observation. Study on 1000 patients | Dan Peretianu, Mara Carsote, Catalina Poiana, Cristina Daniela Staicu | 21. Thyroid (non-cancer) |
| P383 | Hashimoto’s thyroiditis is not associated with breast cancer more than other thyroid condition or more than general population | Mara Carsote, Catalina Poiana, Cristina Daniela Staicu, Dan Peretianu | 21. Thyroid (non-cancer) |
| P384 | OCCURRENCE AND PROGNOSTIC IMPACT OF HYPOTHYROIDISM IN CHRONIC HEART FAILURE | V Triggiani, M Iacoviello, F Monzani, VA Giagulli, E Tafaro, P Guida, E Guastamacchia, S Favale | 21. Thyroid (non-cancer) |
| P385 | Serum Lipid Oxidation and Paraoxonase Enzyme Activity in Subclinical Thyrotoxicosis | Mehrdad Solati, Ladan Atai, Fereidoun Azizi | 21. Thyroid (non-cancer) |
| P386 | Undiagnosed subclinical hypothyroidism, health indicators and cardiovascular risk factors in a Mediterranean population | MT Julián, ML Granada, I Olaizola, C Castell, A Lucas | 21. Thyroid (non-cancer) |
| P387 | Current Results on Urinary Iodide Excretion in Pregnant Women on the Day of Childbirth in Germany | R. Hampel, S. Körber, Ch. Zingler, O. Niederstrasser, H. Below, V. Briese | 21. Thyroid (non-cancer) |
| P388 | Tear cytokines in endocrine ophthalmopathy (EOP) | T Koszegi, A Nagy, E Mezosi, E Gyorgyi, A Ludany, GL Kovacs | 21. Thyroid (non-cancer) |
| P389 | The CT60 and Jo31 polymorphisms of CTLA-4 gene are associated with disease progression in Graves’ disease. | J Daroszewski, E Pawlak-Adamska, M Bolanowski, I Frydecka | 21. Thyroid (non-cancer) |
| P390 | HYPERTHYROIDISM IN PREGNANCY- THERAPEUTIC DECISIONS | EDUARD CIRCO, MIHAELA SECELEANU | 21. Thyroid (non-cancer) |
| P391 | The Association between Serum TSH Levels and Hypertension in 12,353 Children and Adolescents | T Ittermann, M Thamm, H Wallaschofski, R rettig, H Völzke | 21. Thyroid (non-cancer) |
| P392 | Increased Th1 response and regulatory CD4+CD25+CD127low/-FoxP3+ T cells in patients with chronic hepatitis C virus infection developing interferon-induced thyroiditis | B Soldevila, N Alonso, M.J Martínez-Arconada, T Julian, R Planas, R Pujol-Borrell, E.M Martínez-Cáceres, A Sanmartí | 21. Thyroid (non-cancer) |
| P393 | Study of the relation between subclinical hypothyroidism and diabetic complications | H Kameda, S Nagai, C Shimizu, H Nomoto, A Hirai, K Kimachi, KY Cho, A Nakagaki, T Sawada, T Kondo, H Miyoshi, T Koike | 21. Thyroid (non-cancer) |
| P394 | MELATONIN DRUG USE IN COMPLEX TREATMENT OF HYPOTHYROIDISM MANIFEST | Almagul Mansharipova, Gulnar Moldabek, Zhangentkhan Abylaiuly | 21. Thyroid (non-cancer) |
| P395 | MPV levels in patients with overt hypothyroidism before and after levothyroxine treatment | Neslihan Soysal Atile, Betül Ekiz Bilir, Bülent Bilir, Sibel Güldiken, Elçin Atasever | 21. Thyroid (non-cancer) |
| P396 | Epidemiologic Study of Iodine Deficiency in 6 regions of the Republic of Uzbekistan | SI Ismailov, LB Nugmanova, BKh Babakhanov | 21. Thyroid (non-cancer) |
| P397 | Thyroid status and health-related quality of life in the LifeLines-cohort | E.I. Klaver, R. Stienstra, M.M. van der Klauw, I.P. Kema, B.H.R. Wolffenbuttel | 21. Thyroid (non-cancer) |
| P398 | Subclinical hypothyroidism and thyroid autoimmunity: risk factors for coronary heart disease? | Z. Milicevic, J. Ciric | 21. Thyroid (non-cancer) |
| P399 | Faster response to cholestyramine added in treatment of patients with hyperthyroidism | I.E. Bonapart, A. Boumpaki, A. Stamataki | 21. Thyroid (non-cancer) |
| P400 | The expression of keratin 34βE12 in ectopic thymus tissue | R Cornea, M Cornianu, E Lazar, A Dema, S Taban, A Muresan, C Lazureanu, I Golu | 21. Thyroid (non-cancer) |
| P401 | PARATHYROID CYST, A RARE CAUSE OF CYSTIC THYROID LESION | C Ghervan, P Goel, I Duncea | 21. Thyroid (non-cancer) |
| P402 | CLINICAL ASPECTS IN GRAVES’ DISEASE ASSOCIATED WITH INFILTRATIVE ORBITOPATHY | M. Balas, I. Golu, M. Vlad, C. Gurban, I. Zosin | 21. Thyroid (non-cancer) |
| P403 | Thyroid Nodules in Children – Review of 67 patients | J Mesquita, S Paco Lima, MJ Matos, F Neiva, S Paupério, S Martins, C Costa, C Castro Correia, Davide Carvalho, Manuel Fontoura | 21. Thyroid (non-cancer) |
| P404 | THE ETIOLOGIC PROFILE OF THYROMEGALY IN CHILDREN IN THE SOUTH WEST OF ROMANIA BETWEEN 2005-2010 | Marginean Otilia, Varcus Flore, Simedrea Ioan, Dora Andor, Tamara Marcovici, Rodica Ilie | 21. Thyroid (non-cancer) |
| P405 | Awareness of secondary hypothyroidism in growth hormone deficient hypopituitary adults has improved their lipid status. | M-L Hartoft-Nielsen, M Klose, O Klefter, V Gavan, ÅK Rasmussen, U Feldt-Rasmussen | 21. Thyroid (non-cancer) |
| P406 | CYTOLOGICAL EVALUATION OF PYRAMIDAL LOBE AND THYROGLOSSAL DUCT CYSTS | Ayten Oguz, Husniye Baser, Dilek Tuzun, Alper Usluogullari, Ali A. Tam, Reyhan Ersoy, Gulnur Guler, Bekir Cakir | 21. Thyroid (non-cancer) |
| P407 | The outcome of radioiodine therapy after ten years in patient with toxic nodular goiter | Saeid Abdelrazek, Franciszek Rogowski,, Piotr Szumowski, Malgorzata Szorc, Maria Gorska, Malgorzata Szelachowska | 21. Thyroid (non-cancer) |
| P408 | The effect of radioiodine therapy in patients with non-toxic goiter with hot nodules on thyroid scan | Saeid Abdelrazek, Franciszek Rogowski, Malgorzata Szelachowska, Malgorzata Szorc, Malgorzata Mojsak | 21. Thyroid (non-cancer) |
| P409 | The induction of hyperthyroidism in patient with non-toxic goiter after radioiodine therapy: a case report | Saeid Abdelrazek, Franciszek Rogowski | 21. Thyroid (non-cancer) |
| P410 | Lithium in the acute preoperative preparation of thyrotoxicosis – a case series | s Dampetla, M Malik | 21. Thyroid (non-cancer) |
| P411 | Thyroid peroxidase antibodies in euthyroid children- Is long term follow up required? | K Tharian, C Evans, J T Warner | 21. Thyroid (non-cancer) |
| P412 | Increasing saturation with thyroid hormones is associated with haemostatic system activation | J Horacek, J Maly, I Svilias, M Zidkova, Z Pavlikova, M Pecka, E Malirova, J Vizda | 21. Thyroid (non-cancer) |
| P413 | Sclerosing Hashimoto’s Thyroiditis: A Case Presentation | F Talbot, S Krishnan, A Mathews, A Marker, P Jani, K Chatterjee | 21. Thyroid (non-cancer) |
| P414 | Does levothyroxine plus thyrostatic drug titrated individually offer better control of hyperthyroidism than thyrostatic alone? | Josip Žmire, Kristijan Peroš, Kristina Kljajić, Krešimir Martinac, Bože Čolak, Marijana Vučić Lovrenčić, Lea Sokolić | 21. Thyroid (non-cancer) |
| P415 | Free T4 results in neonates: large differences between Immulite/VISTA and Vitros ECi | F. Weerkamp, R.W. Wulkan | 21. Thyroid (non-cancer) |
| P416 | N-terminal pro B type natriuretic peptide levels in thyroid dysfunctions | Husniye Baser, Salih Baser, Nazli Gulsoy Kirnap, Murat Sakaci, Gul Gursoy | 21. Thyroid (non-cancer) |
| P417 | Thyroid hormone levels are associated with body composition in healthy men | G Roef, S Guillemaere, S Vandewalle, H De Naeyer, Y Taes, J-M Kaufman | 21. Thyroid (non-cancer) |
| P418 | The efficacy of real-time ultrasound elastography in evaluation of thyroid nodules | M. Gietka-Czernel, M. Kochman, K. Bujalska, E. Stachlewska-Nasfeter, W. Zgliczynski | 21. Thyroid (non-cancer) |
| P419 | SERUM TOTAL SELENIUM LEVELS IN A COHORT OF EUTHYROID PATIENTS WITH MILD THYROID OPHTHALMOPATHY: A CONTROLLED STUDY | G.E. Krassas, N. Pontikides, E. Memi, M. Bougoulia, K. Tziomalos, K. Boboridis | 21. Thyroid (non-cancer) |
| P420 | Analysis of T regulatory cells in young patients with dynamic of Graves’ disease and Hashimoto’s thyroiditis | A Bossowski, M Moniuszko, M Dabrowska, M Mrugacz, B Sawicka, A Bossowska, M Jeznach, A Bodzenta-Lukaszyk | 21. Thyroid (non-cancer) |
| P421 | Effects of thyroxin on pituitary and plasma growth hormone levels in thyroidectomized – diabetic rats | Z. Milicevic, J. Ciric | 21. Thyroid (non-cancer) |
| P422 | THE INCIDENCE OF THYROID NODULES IN AUTOIMMUNE THYROIDITIS IN ONE ENDEMIC AREA | Mihaela Stanciu, Florina Popa, Alina Pascu, Ioan Gheorghe Totoian | 21. Thyroid (non-cancer) |
| P423 | The regulatory role of neuroprotective nerve growth factor in Graves’ ophthalmopathy. | Ildiko Molnar, Agota Bokk | 21. Thyroid (non-cancer) |
| P424 | Biochemical abnormalities in MCT8 patients are due to abnormal thyroid hormone release from the thyroid and altered D1 activity | W.E. Visser, P. Vrijmoeth, H. van Toor, T.J. Visser | 21. Thyroid (non-cancer) |
| P425 | Changes in urinary iodine status following 10-year voluntary salt iodization in Latvia | I. Konrade, M. Makrecka, M. Dambrova, L. Neimane, I. Strele, U. Gruntmanis, A. Lejnieks, V. Pirags | 21. Thyroid (non-cancer) |
| P426 | Triiodothyronine stimulates cystatin C production and glucose transport in bone cells | Ch Schmid, C Ghirlanda, C Zwimpfer | 21. Thyroid (non-cancer) |
| P427 | Acoustic Radiation Force Impulse Elastography (ARFI) in patients with autoimmune thyroid disease | M. Vlad, I Zosin, M. Balas, I. Sporea, S. Bota, A. Popescu, A. Popa, S. Radu | 21. Thyroid (non-cancer) |
| P428 | Proliferative potential of normo- and hyperfunctioning thyroid nodules | Marioara Cornianu, Alis Dema, Ioana Golu, Sorina Taban, Mihaela Vlad, Elena Lazar, Codruta Lazureanu, Mirela Grigoras | 21. Thyroid (non-cancer) |
| P429 | The effect of age on thyroid function and diagnostic significance of TRH test in elderly people | SPP Popovic-Pejicic, AP Pejicic | 21. Thyroid (non-cancer) |
| P430 | Improved prognosis in myxedema coma – happy ending of an old story- Case report | Ioana Vasiliu, Cristina Preda, Ioana Grigoras, Alexandru Florescu, Roxana Balcan, Jeanina Idriceanu, Voichita Mogos, Carmen Vulpoi | 21. Thyroid (non-cancer) |
| P431 | The immunohistochemical demonstration of parafollicular cells and evaluation of calcium-phosphate balance in patients with thyroid hemiagenesis | Ewelina Szczepanek, Marek Ruchala, Patrycja Sujka-Kordowska, Maciej Zabel, Maciej Biczysko, Jerzy Sowinski | 21. Thyroid (non-cancer) |
| P432 | The influence of radioiodine therapy on ophthalmologic symptoms and their relation to urine cotinine level in patients with Graves' disease | Agata Czarnywojtek, Marek Ruchala, Rafal Czepczynski, Ewelina Szczepanek, Ewa Florek, Hanna Zamyslowska, Izabela Kulinska-Niedziela, Krzesislawa Komar-Rychlicka, Jerzy Sowinski | 21. Thyroid (non-cancer) |
| P433 | TSH Receptor Antibody Measurement in the Diagnosis of Graves’ Disease | Z Ylli, B Dyrmishi, E Puca, G Husi, E Kolici, M Kapia, D Ylli, A Ylli | 21. Thyroid (non-cancer) |
| P434 | Autoimmune hyperthyroidism triggered by 131I treatment for toxic nodular goitre: treatment with a second dose of 131I vs. thyrostatics | Jolanta Kijek, Jerzy St. Tarach, Bozena Szymanek, Maria Kurowska | 21. Thyroid (non-cancer) |
| P435 | THE USEFULNESS OF HUMAN TSH-RECEPTOR ANTIBODY DETERMINATION IN THE ASSESSMENT OF CLINICAL ACTIVITY OF GRAVES’ ORBITOPATHY | A. Vryonidou, V. Loi, N. Klonaris, T. Terzi, O. Karagianni, C. Tzioras | 21. Thyroid (non-cancer) |
| P436 | Postpartum follow-up of women positively screened for thyroid disease in pregnancy: the necessity of a better care | E. Potlukova, J. Jiskra, Z. Telicka, J. Bartakova, D. Springer, Z. Limanova | 21. Thyroid (non-cancer) |
| P437 | CTLA4 exon1 A49G polymorphism in Slovak patients with rheumatoid arthritis and autoimmune thyroid disease. | Ivica Lazúrová, Karim Benhatchi, Ivana Jochmanová, Viera Habalová | 21. Thyroid (non-cancer) |
| P438 | An unusual organ involvement in Werner Syndrome: thyroid atrophy | Mustafa Altay, Mehmet Colbay, Fusun Balos Toruner, Mujde Akturk, Erkam Sancar, Nuri Cakir, Metin Arslan | 21. Thyroid (non-cancer) |
| P439 | Thyroid pathology in patients with type 1 diabetes mellitus | J. Idriceanu, M. Graur, C. Preda, I. Vasiliu, R. Balcan, M.C. Ungureanu, C. Cristea, C. Vulpoi | 21. Thyroid (non-cancer) |
| P440 | GOITER AND EPIDEMIDOLOGY OF AUTOIMMUNE THYROIDITIS | I. Kostoglou-Athanassiou, A. Michou, S. Tagara, A. Chronaiou, A. Liakopoulou, E. Xanthakou, T. Terzi, A. Karfi | 21. Thyroid (non-cancer) |
| P441 | Thyroid - associated ophtalmopathy (TAO) in association with another disorders | Cristina Corina Pop Radu, Jozsef Balazs, Camelia Gliga, Anisie Nasalean, Ionela Pascanu, Imre Kun | 21. Thyroid (non-cancer) |
| P442 | Evaluation of thyroid function test remission and relapse after low dose anti-thyroid drug therapy of Graves’ disease, interim report of a long term retrospective study | HR Bazrafshan, M Steinmair, F Fitz, AR Maleki, I Wolf, C Reichl, M Beheshti, W Langsteger | 21. Thyroid (non-cancer) |
| P443 | LONG-TERM FOLLOW-UP OF THYROID AUTOIMMUNITY BIOMARKERS IN GRAVES’ DISEASE TREATED WITH LOW DOSE ANTI-THYROID MEDICATIONS (INTERIM REPORT) | HR Bazrafshan, F Fitz, M Steinmair, S Haim, C Reichl, M Beheshti, W Langsteger, L Klesov | 21. Thyroid (non-cancer) |
| P444 | Regulation of visceral adipose tissue-derived serin protease inhibitor in overt and subclinical hypothyroid patients | Nese Cinar, Nese Ersoz Gulcelik, Kadriye Aydin, Safak Akin, Aydan Usman, Alper Gurlek | 21. Thyroid (non-cancer) |
| P445 | Thyroid Function and Mortality in Euthyroid Subjects | A Roos, TP Links, ROB Gans, BHR Wolffenbuttel, SJL Bakker | 21. Thyroid (non-cancer) |
| P446 | Vitamin D levels are associated with serum TSH levels but not with thyroid autoantibodies | Mehmet Colbay, Mustafa Altay, Mujde Akturk, Nuri Cakir, Ilhan Yetkin, Metin Arslan | 21. Thyroid (non-cancer) |
| P447 | Evaluation of thyroid surgery: 10 years of experience in a Military Hospital | Mafalda Marcelino, Carlos Lopes, Raquel Carvalho, Paulo Guerra, Dolores Passos, Helena Vilar, Luis Lopes, João Castro | 21. Thyroid (non-cancer) |
| P448 | Fine Needle Aspiration Biopsy in Thyroid Nodular Disease – 10 years of experience in a Military University Hospital | Mafalda Marcelino, Saudade André, Luisa Figueiredo, Dolores Passos, Helena Vilar, Luis Lopes, Raquel Carvalho, João Castro | 21. Thyroid (non-cancer) |
| P449 | Routine serum calcitonin measurement in screening of medullary thyroid carcinoma (MTC) in Gohierri county. Juan Marti. M Mar Galar Department of Internal Medicine and Biochemistry Laboratory. Hospital Zumárraga. Guipúzcoa. Spain. | J Marti, M M Galar | 22. Thyroid cancer |
| P450 | COEXISTENCE OF HYPERPARATHYROIDISM WITH PAPILLARY THYROID MICROCARCINOMA | MR Diaconescu, M Glod, I Costea, S Diaconescu | 22. Thyroid cancer |
| P451 | RECOMBINANT TSH-STIMULATED THYROGLOBULIN MEASUREMENTS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA WITH BASAL THYROGLOBULIN | A Vieira, F Carrilho, C Ribeiro, M Melo, M Alves, S Gouveia, J Saraiva, M Carvalheiro | 22. Thyroid cancer |
| P452 | THYROID DISEASE IN PATIENTS WITH TYPE-1 NEUROFIBROMATOSIS: AN UNDERESTIMATED ISSUE? | C. Diazzi, A. Guidi, A. Luberto, E. Taliani, B. Madeo, V. Rochira, C. Carani | 22. Thyroid cancer |
| P453 | Papillary Thyroid Microcarcinoma: Size and Metastatic Behavior | O Demiduk, I Avetisian, P Malyarevskyy, S Tsimbaluk, A Dinets, M Hulchiy | 22. Thyroid cancer |
| P454 | Estrogen receptors and progesterone receptor expression and their relationship to types of thyroid cancer | José Cameselle-Teijeiro, Lara Alberte-Lista, Diego Peteiro-González, Miguel Melo, Ihab Abdulkader, Paula Soares, Pilar Gayoso-Diz, Manuel Sobrinho-Simões | 22. Thyroid cancer |
| P455 | The Effects of Four Different Tyrosine Kinase Inhibitors on Medullary and Papillary Thyroid Cancer Cells | HHG Verbeek, MM Alves, JWB de Groot, J Osinga, JTM Plukker, TP Links, RMW Hofstra | 22. Thyroid cancer |
| P456 | Thr300Ala ATG16L1 polymorphism influences susceptibility to and the prognosis of epithelial cell derived thyroid carcinoma | A Huijbers, T.S. Plantinga, M Oosting, L.A.B. Joosten, K.K.H. Aben, M.G. Netea, A.R.M.M. Hermus, R.T. Netea-Maier | 22. Thyroid cancer |
| P457 | Reversine, an anti-cancer candidate, induces cell cycle arrest and apoptosis in human thyroid cancer | Ying-Ray Lee, Shih-Che Hua, Shu-Hsin Chen, Chieh-Hsiang Lu, Hui-I Yu, Hau-Ren Chen, Tien-Chun Chang | 22. Thyroid cancer |
| P458 | Intraindividual Comparison of Serum Calcitonin Levels after Calcium versus Pentagastrin Stimulation | R Hampel, J Laue, Ch Zingler, B Klar | 22. Thyroid cancer |
| P459 | Classical and follicular variant papillary thyroid carcinoma: comparison of clinical, ultrasonographical, cytological and histopathological features in 402 patients | Didem Ozdemir, Reyhan Ersoy, Neslihan Cuhaci, Dilek Arpaci, Eren P Ersoy, Birol Korukluoglu, Gulnur Guler, Bekir Cakir | 22. Thyroid cancer |
| P460 | Serum 25-OH Vitamin D levels in patients with benign and malignant thyroid nodules | Didem Ozdemir, Husniye Baser, Fevzi Balkan, Dilek Arpaci, Reyhan Ersoy, Bekir Cakir | 22. Thyroid cancer |
| P461 | Role of 99mTc HYNIC Octreotide in the follow up of thyroid cancer patients that after surgery and 131I therapy present raised thyroglobulin levels and negative 131I whole body scan | MP Serra, O Alonso, C De los Santos, JC Hermida, A Quagliata, JP Gambini, Y Tochetto, G González | 22. Thyroid cancer |
| P462 | A case of calcitonin and CEA negative medullary thyroid carcinoma | GL Kovacs, J Denes, E Hubina, L Kovacs, E Lahm, R Kosa, A Voros, M Goth | 22. Thyroid cancer |
| P463 | COMPARISON OF CLINICAL AND HISTOPATHOLOGICAL CHARACTERISTICS OF THYROID PAPILLARY MICROCARCINOMA AND PAPILLARY THYROID CARCINOMA | Ersin Akarsu, Mehmet Metin Sevim, Müge Özsan, Suna Erkılıç, Mustafa Araz | 22. Thyroid cancer |
| P464 | Both Follicular and Papillary neoplasms in a patient with Hashimoto’s Thyroiditis: Complete coincidence? | U MOUSA, N.B. TUTUNCU | 22. Thyroid cancer |
| P465 | ASSOCIATION BETWEEN THYROID AUTOIMMUNITY AND PAPILLARY THYROID CARCINOMA: RECENT CONFIRMATIONS FROM A PROSPECTIVE STUDY | F. Boi, A. Borghero, M.L. Lai, S. Casula, I. Maurelli, P.G. Calò, A. Nicolosi, S. Mariotti | 22. Thyroid cancer |
| P466 | Primary malignant thyroid teratoma combined with papillary thyroid carcinoma in a female patient with Hashimoto thyroiditis | C T Tsentidis, V M Vaslamatzis, P S Pinis, M K Karayanni, C V Vasilopoulos, A A Argyropoulos | 22. Thyroid cancer |
| P467 | Differences between incidental and preoperatively diagnosed papillary thyroid microcarcinomas. Review of the last decade | M. Paja, A. Oleaga, A. Ugalde, A. Expósito, C. Moreno, M. Sánchez-Goitia, A.J. Izuzquiza, J.R. Elorza | 22. Thyroid cancer |
| P468 | DIAGNOSTIC VALUE OF ELASTOSONOGRAPHICALLY DETERMINED STRAIN INDEX IN THE DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT THYROID NODULES | Bekir Cakir, Cevdet Aydin, Birol Korukluoglu, Didem Ozdemir, Cagatay I. Sisman, Dilek Tuzun, Ayten Oguz, Gulnur Guler, Guven Guney, Ahmet Kusdemir, Yavuz S. Sanisoglu, Reyhan Ersoy | 22. Thyroid cancer |
| P469 | DIAGNOSTIC VALUE OF ELASTOSONOGRAPHICALLY DETERMINED STRAIN INDEXES IN DIFFERENTIATED THYROID CARCINOMAS | Bekir Cakir, Birol Korukluoglu, Cevdet Aydin, Dilek Tuzun, Cagatay I. Sisman, Ayten Oguz, Didem Ozdemir, Gulnur Guler, Güven Güney, Ahmet Kusdemir, Yavuz S. Sanisoglu, Reyhan Ersoy | 22. Thyroid cancer |
| P470 | An Uncommon Thyroid Tumor: Hyalinizing Trabecular Adenoma | Ozen Oz Gul, Soner Cander, O.K Unal, O Saraydaroglu, C Ersoy, E Erturk, E Tuncel, S Imamoglu | 22. Thyroid cancer |
| P471 | Differentiated thyroid cancer: primary tumor size and clinicopathologic features | R Rangel, A Afonso, L Matos, F Fonseca, L Cortez, T Sabino, J Coutinho, A Agapito | 22. Thyroid cancer |
| P472 | Incidental Papillary Thyroid Microcarcinoma: a retrospective study | R Rangel, A Afonso, L Matos, F Fonseca, L Cortez, P Tavares, A Agapito | 22. Thyroid cancer |
| P473 | Clinicopathologic significance of BRAF mutation in Papillary Thyroid Carcinoma | J Sastre, Y Campos, O LLamazares, JL Orradre, A Vicente, A Marco, S Aso, J Lopez | 22. Thyroid cancer |
| P474 | Diagnostic performance and concordance analysis between ultrasonographic findings suggestive of malignancy and Fine-Needle Aspiration (FNA) in eufunctional thyroid nodule | H Vargas-Uricoechea, I Meza Cabrera, C Gómez Astaiza | 22. Thyroid cancer |
| P475 | Prevalence and features of incidental thyroid carcinoma in 1955 patients surgically treated for benign lesions | M Perrino, C Colombo, L Vicentini, G Cantoni, L Poggi, P Beck-Peccoz, L Fugazzola | 22. Thyroid cancer |
| P476 | FAILURE TO SUPRESS TSH LEVEL IN A THYROID CANCER PATIENT; A CASE REPORT | Arzu Gedik, Merve Yilmaz, Tugba Gumus, Mehmet Calan, Mujde Soyturk, Abdurrahman Comlekci | 22. Thyroid cancer |
| P477 | Long term follow-up and outcome in thyroid papillary microcarcinoma | B Vlassopoulou, A Vryonidou, D Ioannidis, A Koletti, N Klonaris, C Katsoulis, Ch Vasilopoulos, I Tzavara | 22. Thyroid cancer |
| P478 | Incidentally discovered thyroid carcinomas. An experience of a centre through 18 years. | Aitzol Lizarraga, Miguel Paja, Maider Sanchez, Borja Barrios, Josu Perez, Vanessa Arosa | 22. Thyroid cancer |
| P479 | Evaluation of safety and tolerability of calcitonin stimulation using high-dose calcium in patients with medullary thyroid carcinoma (MTC). | Aldona Kowalska, Iwona Palyga, Danuta Gasior-Perczak, Anna Sluszniak, Stanislaw Gozdz | 22. Thyroid cancer |
| P480 | Comparison of calcitonin stimulation tests with pentagastrin (Pg) and high-dose calcium in patients with medullary thyroid carcinoma (MTC) | Aldona Kowalska, Iwona Palyga, Danuta Gasior-Perczak, Anna Sluszniak, Stanislaw Gozdz | 22. Thyroid cancer |
| P481 | THE VALUE OF CK19, Ki-67 AND p53 EXPRESSION IN THE DIAGNOSIS OF THYROID FOLLICULAR NEOPLASMS | Marioara Cornianu, Alis Dema, Sorina Taban, Ioana Golu, Anca Muresan, Remus Cornea, Elena Lazar, Alexandra Faur | 22. Thyroid cancer |
| P482 | Does Preoperative Fine-Needle Aspiration Decreases the Thyroidectomy Rates? | S Cander, Ö Saraydaroglu, OK Ünal, Ö Öz Gül, A Akkurt, E Ertürk, S Imamoglu | 22. Thyroid cancer |
| P483 | MALIGNANCY RATE IS NOT DIFFERENT IN DOMINANT NODULE AND NON- DOMINANT NODULE BY FINE NEEDLE THYROID ASPIRATION | Omer Yazgan, Fahri Halid Besir, Yusuf Aydin, Sibel Yazgan, Melih Engin Erkan, Burhan Yazici, Ramazan Büyükkaya, Omer Onbas | 22. Thyroid cancer |
| P484 | 7th UICC/TNM staging criteria for medullary thyroid carcinoma: is there any prognostic advantage? | M Martinho, T Azevedo, F Carrilho, T Martins, C Ribeiro, M Melo, N Cunha, MJ Rascão, A Neves, P Gilde, JL Pires, C Cruz, C Oliveira, J Neto, S Oliveira, F Valido, I Gomes, M Carvalheiro, F Rodrigues | 22. Thyroid cancer |
| P485 | Very low-risk papillary thyroid carcinoma: where to set the limits? | M Martinho, T Azevedo, T Martins, N Cunha, MJ Rascão, C Oliveira, J Neto, S Oliveira, P Gilde, A Neves, I Gomes, C Cruz, F Valido, B Campos, F Rodrigues | 22. Thyroid cancer |
| P486 | mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures | C Filieri, MC Zatelli, M Minoia, F Tagliati, M Buratto, MR Ambrosio, M Pelizzo, EC degli Uberti | 22. Thyroid cancer |
| P487 | Synchronous thyroid and gastric diffuse large B cell lymphoma | Mustafa Altay, Fusun Balos; Toruner, Fatih Karakaya, Nuri Cakir, Metin Arslan | 22. Thyroid cancer |
| P488 | Radiodine therapy and age at menopause in women with differentiated thyroid cancer | T Martins, T Azevedo, M Martinho, S Oliveira, J Neto, F Rodrigues | 22. Thyroid cancer |
| P489 | Value of Sonographic Index Point and Resistivity index in the diagnosis of the malignant potential of nodular thyroid disease | V Jain, J N Toppo, K Masih, J J Jacob | 22. Thyroid cancer |
| P490 | Retrospective Analysis of Predictive Factors for Recurrence During Long term follow-up in Papillary Thyroid Cancer Patients Who had remission After Primary Treatment | Özlem Soyluk, Harika Boztepe, Ferihan Aral, Nese Çolak | 22. Thyroid cancer |
| P491 | Factors connected with the female sex - association with differentiated thyroid cancer. | EPM Przybylik-Mazurek, AHD Hubalewska-Dydejczyk, AF Fedorowicz, DP Pach | 22. Thyroid cancer |
| P492 | Does Vitamin D replacement therapy improve insulin sensitivity in elderly? | Ilkin Naharci, Nuri Karadurmus, Ergun Bozoglu, Turker Turker, Huseyin Doruk, Muhittin Serdar | 3. Bone/calcium/Vitamin D |
| P494 | Effects of ibandronate versus risedronate on hip bone density in the osteoporotic elderly | Ilkin Naharci, Ahmet Turan Isik, Ergun Bozoglu, Ozdes Emer, Turker Turker, Metin Uyanik, Muhittin Serdar, Huseyin Doruk | 3. Bone/calcium/Vitamin D |
| P495 | Overweight and risk for osteoporosis | Snezana Polovina, Klara Tucic Nemet, Jelena Micic, Koviljka Milenkovic Vulovic, Dusan Micic, Dragan Micic | 3. Bone/calcium/Vitamin D |
| P496 | Hip and lumbar spine BMD in overweight postmenopausal women | Klara Tucic Nemet, Snezana Polovina, Angelina Obradovic | 3. Bone/calcium/Vitamin D |
| P497 | INCIDENCE OF OSTEOPOROSIS STUDY IN PREMATURE OVARIAN FAILURE | I. Bistriceanu, M.E Preda, M. Bistriceanu, M. Popescu, B. Bicu, L. Putinelu | 3. Bone/calcium/Vitamin D |
| P498 | Bone markers of osteoblast/ osteoclast activity in postmenopausal osteoporosis | C. Gurban, M. Balas, S. Gotia, L. Gotia, D. Drugarin, I. Zosin | 3. Bone/calcium/Vitamin D |
| P499 | Osteoporosis in the Women with Metabolic Syndrome | Lali Kilasonia, Nino Rusia, Luba Lagvilava, Tamara Burchuladze | 3. Bone/calcium/Vitamin D |
| P500 | “Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density” | M Piedra, M. T. García-Unzueta, A. Berja, J. A. Riancho, C. Valero, B. Paule, B. A. Lavín, J. A. Amado | 3. Bone/calcium/Vitamin D |
| P501 | Vitamin D deficiency in Spain: a population-based cohort study | I Gonzalez-Molero, S Valdes, S Morcillo, V Perez-Valero, P Botas, E Delgado, E Menendez, F Soriguer | 3. Bone/calcium/Vitamin D |
| P502 | Serum Testosterone and Estradiol in Relation to Bone Mineral Density, Muscle strength and Body Composition in Elderly Men | A.A. Hammad, Z.A. Hassan, F.K. Hamad, D.M. Abaza, K.M. Abdel Hamid, M.E.K. El Wakeel | 3. Bone/calcium/Vitamin D |
| P503 | Differential Gene Expression in Runx2 and Osterix Double Heterozygotes during Skeletal Development | JE Baek, YH Kim, WY Baek, B de Crombrugghe, JY Choi, JE Kim | 3. Bone/calcium/Vitamin D |
| P504 | Sex-Specific Response of Mammalian Bone in Vivo and in Vitro to Estrogens and to Androgens | D Somjen | 3. Bone/calcium/Vitamin D |
| P505 | Insulin sensitivity and bone mineral density in primary hyperparathyroidism | LG Gianotti, FT Tassone, MP Pellegrino, FC Cesario, CB Baffoni, GM Magro, CGC Croce, GB Borretta | 3. Bone/calcium/Vitamin D |
| P506 | Suspected parathyroid lesions and incidentally detected parathyroid adenomas during thyroid ultrasonography | Didem Ozdemir, Dilek Arpaci, Rifki Ucler, Neslihan Cuhaci, Reyhan Ersoy, Bekir Cakir | 3. Bone/calcium/Vitamin D |
| P508 | The diseases which are associated with asymptomatic primary hyperparathyroidism as an aid and obstacle for early diagnosis of the disease, especially arterial hypertension and malignancy | Helena Šiprová, Zdenek Fryšák, Kvetoslav Šipr | 3. Bone/calcium/Vitamin D |
| P509 | DT56a (Femarelle), contrary to Estradiol- 17, has a positive stimulatory effect on human derived female cultured bone cells in hyperglycemic conditions. | D. Somjen, S. Katzburg, O. Sharon, D. Hendel, I. Yoles | 3. Bone/calcium/Vitamin D |
| P510 | Calcium homeostasis in diabetic postmenopausal women with bone fracture | A.A. Gusova, M.G. Pavlova, G.A. Melnichenko, G.M. Kavalersky, L.L. Silin, N.V. Zaitseva | 3. Bone/calcium/Vitamin D |
| P511 | Vitamin D in southern Italy multiple sclerosis patients | C Di Somma, L Vuolo, R Lanzillo, E Guerra, P Contaldi, M Rubino, V Brescia Morra, A Colao | 3. Bone/calcium/Vitamin D |
| P512 | rs219780 SNP of CLDN14 gene is not associated with kidney stones, fractures or bone mineral density in primary hyperparathyroidism | M Piedra, A Berja, M. T. García-Unzueta, M. T. Gutiérrez-Hierro, N. García-LLama, C. Rentería, B. A. Lavín, J. A. Amado | 3. Bone/calcium/Vitamin D |
| P513 | Influence of thyroid disease in diagnostic accuracy of Tc99m-sestamibi scintigraphy in patients with primary hyperparathyroidism (PHP) | Nerea Egaña, Miguel Paja, Maria Teresa Gutierrez, Maria Luisa Rodriguez, Fernando Goñi, Estibaliz Ugarte, Javier Espiga | 3. Bone/calcium/Vitamin D |
| P514 | Secondary hyperparathyroidism in a patient with multiple myeloma | IMR MANDAC ROGULJ, DRK RADIC KRISTO, SOK OSTOJIC KOLONIC, APP PLANINC PERAICA | 3. Bone/calcium/Vitamin D |
| P515 | Bone mineral density and its contributing factors in type 1 diabetic patients | V Zhukouskaya, C Eller-Vainicher, A Shepelkevich, Y Tolkachev, S Koritko, E Cairoli, P Beck-Peccoz, I Chiodini | 3. Bone/calcium/Vitamin D |
| P516 | Hungry bone syndrome following parathyroidectomy | Neslihan Soysal Atile, Betül Ekiz Bilir, Sibel Güldiken | 3. Bone/calcium/Vitamin D |
| P517 | Genome-wide Association In the Rotterdam Study Implicates the 16q24 Locus As Determinant of Osteoporotic Vertebral Fractures | HLDW Oei, K Estrada, MC Castano-Betancourt, M van der Klift, JM Kerkhof, A Hofman, HAP Pols, L Stolk, JB van Meurs, MC Zillikens, AG Uitterlinden, F Rivadeneira | 3. Bone/calcium/Vitamin D |
| P518 | Bone turnover markers and the metabolic syndrome | S.E Oros, O Ianas, D Manda, R.I Rosca, O.M Popa, S Vladoiu, C Dumitrache | 3. Bone/calcium/Vitamin D |
| P519 | Trace elements and bone mineral density in pre- and postmenopausal women | Homayoun Sheikholeslami, Mahmood Gharbavi, Kamillia Kani, Sara Sheikholeslami | 3. Bone/calcium/Vitamin D |
| P520 | Fahr’s syndrome in a patient with unknown hypoparathyroidism | Joana Nicolau Ramis, Anna Espino Ibáñez, Carla Francés Artigas, Rosmeri Rivera Irigoin, Josefina Olivares Alcolea, Luis Alberto Gómez Gómez, Irene Rodríguez Rodríguez, Lluis Masmiquel Comas | 3. Bone/calcium/Vitamin D |
| P521 | Antagonism between body weight and adipocytokines on bone mass acquisition in pre- and postmenopausal women | Buta Corina, Branisteanu Dumitru, Preda Cristina, Ungureanu Didona, Gaspar Ioana, Novac Roxana, Mogos Voichita, Vulpoi Carmen | 3. Bone/calcium/Vitamin D |
| P523 | VITAMIN D AND BONE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS | L Vuolo, V Carnovale, E Guerra, M Rubino, P Contaldi, F Rengo, A Colao, C Di Somma | 3. Bone/calcium/Vitamin D |
| P524 | Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women | A Markatseli, E Hatzi, I Bouba, I Georgiou, A Challa, S Tigas, A Tsatsoulis | 3. Bone/calcium/Vitamin D |
| P525 | Efficacy of Alendronate treatment in women with postmenopausal osteoporosis – results after 3-year study | Lisnic Natalia, Florescu Alexandru, Loghin Andra iulia, Galesanu Corina | 3. Bone/calcium/Vitamin D |
| P526 | Bisphosponates therapy in women with post-menopausal osteoporosis – comparative results | Galesanu Corina, Florescu Alexandru, Loghin Andra Iulia, Lisnic Natalia | 3. Bone/calcium/Vitamin D |
| P527 | Experience with Cinacalcet in Primary Hyperparathyroidism: Results from the Swiss Primary Hyperparathyroidism Cohort Study | A Trombetti, C Meier, C Henzen, C Torriani, A Rohrer, F.R. Herrmann, M Braendle, E.R Christ, ME Kraenzlin, R Rizzoli | 3. Bone/calcium/Vitamin D |
| P528 | Diabetes mellitus and the incidence of fracture | A.A. Gusova, M.G. Pavlova, G.A. Melnichenko, G.M. Kavalersky, L.L. Silin, N.V. Zaitseva | 3. Bone/calcium/Vitamin D |
| P529 | The postprandial response of bone turnover in β-thalassemia major | M Yavropoulou, X Tsekmekidou, K Tomos, E Chasapopoulou, P Chalkia, M Karamouzis, J Yovos | 3. Bone/calcium/Vitamin D |
| P530 | RECENT CHANGES IN CLINICAL PRESENTATION AND THERAPEUTIC APPROACH OF PRIMARY HYPERPARATHYROIDISM IN MEN1 PATIENTS | Rosa Severino, Valeria Ramundo, Francesco Milone, Gaetano Lombardi, Annamaria Colao, Antongiulio Faggiano | 3. Bone/calcium/Vitamin D |
| P531 | RESTITUTION OF SEVER BONE CHANGES AFTER SUCCSESSFUL TREATMENT OF PRIMARY HYPERPARATHYROIDISM | Jovanka Novakovic-Paro, Branka Kovacev-Zavisic, Tijana Icin, Ivana Bajkin, Djordje Popovic, Bojan Vukovic, Milena Mitrovic, Milica Medic-Stojanoska | 3. Bone/calcium/Vitamin D |
| P532 | INTRATHYMIC LOCALISATION OF PARATHYROID ADENOMA-CASE REPORT | B Kovacev-Zavisic, J Novakovic-Paro, T Icin, I Bajkin, B Vukovic, Dj Popovic, M Medic-Stojanoska | 3. Bone/calcium/Vitamin D |
| P533 | THYROID GLAND DISFUNCTION AND OSTEOPOROSIS IN ELDERLY PEOPLE | Snezana Djurica, Miljanka Vuksanovic, Branka Arsenovic | 3. Bone/calcium/Vitamin D |
| P534 | DIETARY FRUCTOSE INHIBITS LACTATION-INDUCED ADAPTATIONS IN RAT CALCITRIOL SYNTHESIS AND CALCIUM TRANSPORT | V Douard, T Suzuki, Y Sabbagh, S Shapses, RP Ferraris | 3. Bone/calcium/Vitamin D |
| P535 | Prevalence of metabolic bone disease in Wilson’s disease (WD) patients | Sofia Teixeira, Joana Domingos, Rui Carvalho, Helena Pessegueiro Miranda, Marina Magalhães | 3. Bone/calcium/Vitamin D |
| P536 | TOTAL PARATHYROIDECTOMY WITHOUT AUTOTRANSPLANTATION IN THE SURGICAL TREATMENT OF "REFRACTORY" RENAL HYPEPARATHYROIDISM | Mihai Radu Diaconescu, Mihai Glod, Ioan Costea, Mirela Grigorovici, Smaranda Diaconescu | 3. Bone/calcium/Vitamin D |
| P537 | The efficacy of four monthly 200,000 IU vitamin D3 supplementation to treat vitamin D deficiency in institutionalized elderly | Veronica Mocanu, Magda Badescu, Roxana Costan, Florin Zugun, Raluca Haliga, Corina Galesanu | 3. Bone/calcium/Vitamin D |
| P538 | Recurrent primary hyperparathyroidsim | E Slotema, F Sebag, JF Henry | 3. Bone/calcium/Vitamin D |
| P539 | VITAMIN D AND DARK SKIN | I. Kostoglou-Athanassiou, A. Michou, E. Xanthakou, A. Chronaiou, S. Tagara, V. Loi, K. Tzioras, A. Karfi | 3. Bone/calcium/Vitamin D |
| P540 | Comparison of Oral versus Intramuscular Treatment of Vitamin D Deficiency or Insufficiency | Seyed Adel Jahed, Mahan shahrivari, Mozhdeh Zabihiyeganeh, Madjid Shakiba | 3. Bone/calcium/Vitamin D |
| P541 | Outcomes of parathyroidectomy with autotransplantation in nephrogenic secondary hyperparathyroidism | Alina Georgescu, Bogdan Stanescu, Adrian Zugravu, Gabriel Mircescu, Corin Badiu | 3. Bone/calcium/Vitamin D |
| P542 | Pseudohypoparathyroidism and GNAS epigenetic alterations: quantitative analysis of methylation defects and correlation with clinical characteristics | FM Elli, AM Barbieri, L de Sanctis, V Bollati, P Beck-Peccoz, A Spada, G Mantovani | 3. Bone/calcium/Vitamin D |
| P543 | Does total parathyroidectomy with autotransplantion simplify reinterventions for persistent or recurrent secondary hyperparathyroidism? | E Slotema, JF Henry | 3. Bone/calcium/Vitamin D |
| P544 | Bone turnover markers and vitamin D status over a training year in female elite alpine skiers | G Lombardi, A Colombini, M Freschi, R Tavana, H Schoenhuber, G Banfi | 3. Bone/calcium/Vitamin D |
| P545 | Some epidemiological aspects of primary hyperparathyroidism in Russia | Liliya Rostomyan, Natalya Mokrysheva, Svetlana Mirnaya, Nataliya Kirdyankina, Liudmila Rozhinskaya | 3. Bone/calcium/Vitamin D |
| P546 | Conservative therapy by cinacalcet for primary hyperparathyroidism management – first results of two center prospective study | Peter Kentoš, Adriana Banárová, Mikuláš Pura, Peter Vanuga, Juraj Payer | 3. Bone/calcium/Vitamin D |
| P547 | The QUS fracture risk groups – unifactorial analyze regarding bone markers and DXA assessment | Mara Carsote, Corina Chirita, Valentin Radoi, Cristina Ene, Adriana Gruia, Gabriela Voicu, Catalina Poiana, Mihail Coculescu | 3. Bone/calcium/Vitamin D |
| P548 | Bone density in patients with ACTH-dependent and ACTH-independent Cushing syndrome | Peter Vanuga, Peter Kentoš, Mikuláš Pura | 3. Bone/calcium/Vitamin D |
| P548.1 | Effects of Atorvastatin and Rosuvastatin Therapy on Serum 25-hydroxyvitamin D Levels: A comparative study | | 3. Bone/calcium/Vitamin D |
| P549 | Hashimoto’s Disease Presenting as Cardiac Tamponade | RASHMI KHANAL, TARUN SHARMA, FAHAD AZIZ | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P550 | The relation between metabolic syndrome and cognitive decline in elderly turkish people | Sayid Shafi Zuhur, Berrin Karadag, Yuksel Altuntas | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P551 | Relationship between N-terminal pro-B-type natriuretic peptide Levels and Metabolic Syndrome | Yuanyuan Bao, Xiliang Shang, Linuo Zhou, Renming Hu | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P552 | Inflammation indices and insulin resistance in metabolic syndrome with and without Coronary Artery Disease | Mojtaba Khademi, Marzieh Nikparvar, Shahram Zare, Mehrdad Solati | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P553 | Regulation of fuel metabolism during exercise in hypopituitarism with growth hormone-deficiency (GHD) | ER Christ, S Alleman, A Egger, C Stettler | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P554 | Prevalence of androgen deficiency in males with metabolic syndrome: Relation between hormonal and metabolic parameters | Antonio Becerra, Gilberto Perez-Lopez, Miriam Menacho, Jose M. Rodriguez-Molina, Mª Jesus Lucio, Nuria Asenjo, Rosa Villar | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P555 | Polycystic ovary syndrome and their relationship with metabolic syndrome in female-to-male transsexuals | Antonio Becerra, Gilberto Perez-Lopez, Miriam Menacho, Jose Miguel Rodriguez-Molina, Mª Jesus Lucio, Nuria Asenjo | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P556 | Is Metabolic syndrome a useless category in subjects with high cardiovascular risk? Results from a cohort study in men with erectile dysfunction | Giovanni Corona, Matteo Monami, Giulia Rastrelli, Alessandra Sforza, Gianni Forti, Edoardo Mannucci, Mario Maggi | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P557 | Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction. | Giovanni Corona, Giulia Rastrelli, Valentina Boddi, Matteo Monami, Alessandra Sforza, Gianni Forti, Edoardo Mannucci, Mario Maggi | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P558 | Body mass index regulates hypogonadism-associated CV risk: results from a cohort of subjects with erectile dysfunction | Giovanni Corona, Giulia Rastrelli, Matteo Monami, Alessandra Sforza, Gianni Forti, Edoardo Mannucci, Mario Maggi | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P559 | Severe Depressive Symptoms and Cardiovascular Risk in subjects with Erectile Dysfunction | Elisa Bandini, Alessandra Fisher, Giovanni Corona, Valdo Ricca, Matteo Monami, Gianni Forti, Edoardo Mannucci, Mario Maggi | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P560 | Priapus is Happier with Venus than with Bacchus | Giovanni Corona, Valentina Boddi, Matteo Monami, Alessandra Fisher, Elisa Bandini, Gianni Forti, Edoardo Mannucci, Mario Maggi | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P561 | YOUNG WOMEN WITH THE POLYCYSTIC OVARY SYNDROME (PCOS) HAVE EVIDENCE OF ENDOTHELIAL DYSFUNCTION BUT NOT OF ALTERED ARTERIAL STRUCTURE. | I Duncea, IR Ilie, C Georgescu, I Marian, T Mocan, B Man, C Brad, G Hazi | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P562 | METABOLIC SYNDROME AND THE EFFECT OF TESTOSTERON TREATMENT IN YOUNG MEN WITH CONGENITAL HYPOGONADOTROPHIC HYPOGONADISM | A Sonmez, C Haymana, E Bolu, A Aydogdu, S Tapan, M Serdar, B Altun, C Barcin, A Taslipinar, C Meric, G Uckaya, M Kutlu | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P563 | Determinants and outcome of amiodarone-associated thyroid dysfunction | S Ahmed, I.C Van Gelder, A.C.P Wiesfeld, D.J Van Veldhuisen, T.P Links | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P566 | Apolipoprotein A1 and B100 and hormones in postmenopausal women | S.E Oros, O Ianas, D Manda, R.I Rosca, S Vladoiu, O.M Popa, M Giurcaneanu, C Dumitrache | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P567 | Cortisol secretion and HPA axis activity in patients undergoing coronary angiography | T Isailovic, M Petakov, Dj Macut, J Antic, S Ognjanovic, B Popovic, I Bozic, V Elezovic, Tamara Bogavac, Svetozar Damjanovic | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P568 | Plasma levels of the Neurohormones A and B-type Natriuretic Peptides Increases after Weight loss in Severe Obesity | C Kistorp, R Christensen, JP Goetze, H Bliddal, J Faber | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P569 | α-defensins are Novel Biomarkers of Low Grade Inflammation with Strong Prognostic Impact in Patients with Heart Failure | C Kistorp, HM Christensen, J Frystyk, A Flyvbjerg, P Hildebrandt, M Schou, J Faber | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P570 | B-type natriuretic peptide modulates the response to intravenous glucose in a placebo-controlled cross-over study in healthy volunteers | B Heinisch, G Vila, M Resl, M Riedl, A Luger, G Pacini, M Clodi | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P571 | D-Lys-GHRP-6, an antagonist of ghrelin receptor type 1a, did not antagonize the effect of acylated ghrelin but antagonized the effect of unacylated ghrelin on the growth of HECa10 murine endothelial cell line | G. Melen-Mucha, J. Polowinczak-Przybylek | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P572 | PHOSPHATE LEVELS INVERSELY CORRELATE WITH AORTIC STIFFNESS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM | Fanni Athanasouli, Leonidas Papadopoulos, Anastasia Vemmou, Konstantine Chalaris, Evelin Efthimiou, Theodore Athanasoulis, Christos Papamichael, Kimon Stamatelopulos, Evangelos Terpos, Maria Alevizaki | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P573 | Low Sex hormone binding globulin – strong association with metabolic syndrome in patients with acute coronary syndrome | JP Payer, AB Banarova, TK Koller, PJ Jackuliak | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P574 | THYROID AND PARATHYROIDS` DISFUNCTION IN PATIENTS SUFFERING FROM CHRONIC RENAL FAILURE | Snezana Djurica, Miljanka Vuksanovic, Branka Arsenovic | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P575 | POSSIBLE ASSOCIATION BETWEEN POLYUNSATURATED FATTY ACIDS AND PARAMETERS OF METABOLIC SYNDROME IN TYPE 2 DIABETES MELLITUS-PILOT STUDY | Z Rasic-Milutinovic, M Vujovic, V Popovic-Radinovic, J Tica, Z Gluvic, M Lackovic, G Perunicic-Pekovic, T Popovic | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P576 | Parathormone 1-84 in type 2 diabetic patients | M.I. Belovici, M. Buysschaert | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P577 | Rhabdomyolysis associated with fenofibrate: a case report | Derya Öz, Ogün Hatipoglu, Pinar Alarslan, Hafize Kurt, Nuri Fidan, Bilgin Özmen, Zeliha Hekimsoy | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P578 | Utility of brain natriuretic peptide (BNP) as a biomarker of risk assessment in acute pulmonary embolism | Alina Mihaela Pascu, Mariana Radoi, Elena Bobescu, Mihaela Stanciu, Sebastian Ionut Toma, Olivia Ligia Burta | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P579 | Correlation of atherogenic dyslipidemia with other plaque instability biomarkers and outcome in non ST-segment elevation acute coronary syndromes (NSTE-ACS) | Elena Bobescu, Alina Mihaela Pascu, Mariana Radoi, Georgeta Datcu, Dan Dobreanu, Gheorghe Ioan Totoianu, Mihaela Stanciu, Ovidiu Burta | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P581 | Long term recreational physical exercise decreases angina susceptibility and induces cardiovascular protective shifts in nitric oxide synthase, heme oxygenase and matrix metalloproteinase enzyme regulation in rats | R Szabó, A Pósa, Z Szalai, P Szablics, Cs Varga, AM Berkó, K Orbán, F László | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P582 | Heme-oxigenase mediates cardiovascular protection by oestrogen and raloxifene in menopause | A Pósa, Cs Varga, AM Berkó, M Veszelka, R Szabó, K Orbán, I Pávó, F László | 4. Cardiovascular Endocrinology and Lipid Metabolism |
| P583 | MGMT Immunoexpression in Adamantinomatous Craniopharyngiomas’’ | Sayid Shafi Zuhur, Ahmet Murat Musluman, Canan Tanik, Ozcan Karaman, Feyza Yener Ozturk, Hanife Ozkayalar, Yuksel Altuntas | 5. Clinical case reports |
| P584 | Tolvaptan versus conventional treatment in hyponatraemia secondary to syndrome of inappropriate anti-diuretic hormone (SIADH): First case experience in West-Midlands region, UK | Ravi Dandamudi, M Hocking | 5. Clinical case reports |
| P585 | Coexistence of double small insulinomas with a small glucagonoma in a patient with multiple endocrine neoplasia-type 1 (MEN-1) | Sayid Shafi Zuhur, Ozcan Karaman, Sumeyra Yildirim, Sibel Erdamar, Hakan Senturk, Yuksel Altuntas | 5. Clinical case reports |
| P586 | A case report of macronodular adrenal hyperplasia with combined cortisol and aldosterone oversecretion in response to β-adrenergic and vasopressin stimuli | L Papanastasiou, T Pappa, V Tsiavos, E Tseniklidi, A Prevoli, P Tsounas, A Markou, G Piaditis | 5. Clinical case reports |
| P587 | Virilizing ovarian tumor- case report | L Cortez, A Lopes, P Tavares, A Carvalho, A Agapito | 5. Clinical case reports |
| P588 | CONGENITAL ADRENAL HYPERPLASIA AND ADRENAL MYELOLIPOMA – INCIDENTAL OU CAUSAL RELATIONSHIP? | A Vieira, I Paiva, J Santos, M Alves, S Gouveia, J Saraiva, F Carrilho, M Carvalheiro | 5. Clinical case reports |
| P589 | Agenesis of the dorsal pancreas, a rare cause of diabetes: a case report and review of 25 Japanese patients | Masanori Shimodaira, Naoko Kumagai, Kaoru Tsuzawa, Erisa Sorimachi, Minako Kametaka, Kazufumi Honda | 5. Clinical case reports |
| P590 | A case of two novel mutations in the LHCGR gene in a patient with 46,XY DSD | Anastasia Athanasoulia, Sebastian Noe, Günter Stalla | 5. Clinical case reports |
| P591 | X-linked adrenomieloneuropathy presenting as Addison’s disease | I Bilbao, A Yoldi, T Matteucci, C García, M Aranburu, N Egaña, M Alvarez-Coca, M Goena | 5. Clinical case reports |
| P592 | Central Precocious puberty related to a tuber cinereum hamartoma in Neurofibromatosis type 1(NF1): case report | L Vija, C Dumitrescu, C Procopiuc, I Gherlan, A Caragheorgheopol | 5. Clinical case reports |
| P593 | Hypoparathyroidism and Morbus Fahr case report | Biljana Jovanoska, Katerina Adamova, Slavica Subeska Stratrova, Iskra Bitoska | 5. Clinical case reports |
| P594 | Acute Respiratory Distress Syndrome in a nonsurgical transsexual | A Giestas, M Almeida, S Teixeira, A Maia, T Azevedo, D Vaz, I Palma, R Carvalho | 5. Clinical case reports |
| P595 | A unique case of multifocal intrathyroid parathyroid carcinoma | Ivan Kruljac, Petra Sulentic, Maja Berkovic Cigrovski, Davorka Herman Mahecic, Gorana Mirosevic, Mirko Ivkic, Milan Vrkljan | 5. Clinical case reports |
| P596 | Conservative or radical approach in patients with 46XY disorders of sex development? | CS Martin, S Fica, A Miron, C Giulea, D Terzea, S Enache, F Andrei, C Nitipir | 5. Clinical case reports |
| P597 | Use of our Last Pills of Iopanoic Acid in a 33-year-old Patient in Acute Refractory Pulmonary Edema and Thyroid Storm: Requiem for a Useful Therapeutic Agent | E Gomez Hoyos, P de Miguel Novoa, C Montañez Zorrilla, N Garcia de la Torre, M Curras Freixes, R Bover Freire, A Calle Pascual, I Runkle de la Vega | 5. Clinical case reports |
| P598 | Hypocalcemic laryngospasm in the Emergency Department | M.J. van Veelen, M.F. Visser, M.G.A. Baggen, A. Dees | 5. Clinical case reports |
| P599 | Thyroid storm in the Emergency Department | M.J. van Veelen, L. Yurtsever, E.A. Dubois, M.G.A. Baggen | 5. Clinical case reports |
| P600 | Lady with backache and inadequate work-up for Hypercalcemia for Five years | A Rizwan, M Jumani, I ali, A Jamal, Z Sheikh | 5. Clinical case reports |
| P601 | Primary hyperparathyroidism due to an ectopic intrathymic parathyroid adenoma – case report | M Vlad, M Balas, Al Nicodin, M Cornianu, D Onet, A Popa, I Zosin | 5. Clinical case reports |
| P602 | Clinical case of 48 years old man with panhypopituitarism of unclear etiology | K.Y. Vdovich, Y.E. Poteshkin, V.S. Pronin | 5. Clinical case reports |
| P603 | Unusual case of Congenital Adrenal Hyperplasia: Polymenorrhagia and Markedly High 17 OH Progesterone levels in a lady with Non Classic Congenital Adrenal Hyperplasia | A Rizwan, M Hayat, Z Sheikh | 5. Clinical case reports |
| P604 | Schmidt's Syndrome: Unveiling step-by-step | A Rizwan, M Hayat, Z Sheikh | 5. Clinical case reports |
| P605 | PRIMARY HYPERPARATHYROIDISM IN PREGNANCY- A CASE REPORT | D Grigorie, A Sucaliuc, A Ranetti, M Ivan | 5. Clinical case reports |
| P606 | Primary hypothyroidism due to sublingual thyroid associated with growth failure, hyperprolactinemia and pituitary enlargement. | A. Loghin, A. Florescu, L. Moisii, C. Stefanescu, C. Galesanu | 5. Clinical case reports |
| P607 | HYPOGLYCEMIA IN PATIENT WITH LARGE INTRAABDOMINAL TUMOR | Miomira Ivovic, Svetlana Vujovic, Milina Tancic-Gajic, Ljiljana Marina, Vladimir Djukic, Dusan Micic, Dragan Micic | 5. Clinical case reports |
| P608 | PHEOCHROMOCYTOMA AND PARAGANGLIOMA IN PATIENT WITH EXTIRPATED GANGLIONEUROMA | Ljiljana Marina, Miomira Ivovic, Svetlana Vujovic, Milina Tancic-Gajic, Vlada Zivaljevic, Zorana Arizanovic, Ana Nenezic, Dragan Micic | 5. Clinical case reports |
| P609 | CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA OR BILATERAL ADRENOCORTICAL ADENOMAS? -CASE REPORT | A Lopes, F Fonseca, L Duarte, A Milheiro, A Agapito | 5. Clinical case reports |
| P610 | Cholestatic jaundice methimazole-induced or secondary to heart failure? | SB Souto, P Rodrigues, S Belo, C Nogueira, A Magalhães, JL Castedo, D Carvalho-Braga, D Carvalho | 5. Clinical case reports |
| P611 | Remind familial hypocalciuric hypercalcemia as a cause of elevated parathyroid hormone and serum calcium: 5 patients. | I.E. Bonapart, A. Boumpaki, A. Stamataki | 5. Clinical case reports |
| P612 | Iatrogenic Hypoadrenalism – A Case Report | J Mesquita, A Varela, A Magalhães, F Correia, D Carvalho | 5. Clinical case reports |
| P613 | Diabetes Insipidus in the Context of Sarcoidosis – A Case Report | J Mesquita, P Rodrigues, S Belo, A Sousa, A Varela, A Magalhães, JL Castedo, N Melo, Patricia Mota, Davide Carvalho | 5. Clinical case reports |
| P614 | A CASE OF SMALL CELL LUNG CANCER OF WHICH FIRST FINDING IS HYPONATREMIA | Dilek Tuzun, Ayten Oguz, Neslihan Cuhaci, Aysegul Senturk, Nurullah Zengin, Reyhan Ersoy, Bekir Cakir | 5. Clinical case reports |
| P615 | EVALUATION OF AUTOIMMUNE ENDOCRINE DISTURBANCES IN CELIAC PATIENTS | Ayten Oguz, Ebru Akin, Dilek Tuzun, Aylin B. Demirezer, Osman Ersoy, Reyhan Ersoy, Bekir Cakir | 5. Clinical case reports |
| P616 | Autoimmune Polyglandular Endocrinopathy Associated with Collagenous Sprue: A Case Report | Serap Soytac Inancli, Arzu Ensari, Esin Beyan, Berna Savas, Ekrem Abayli | 5. Clinical case reports |
| P617 | Iatrogenic Lymphocytic Hypophysitis | P SHILLO, R EVANS, J WRIGHT, J NEWELL PRICE | 5. Clinical case reports |
| P618 | A RARE CAUSE OF NONTRAUMATIC RHABDOMYOLYSIS: CENTRAL DIABETES INSIPIDUS | Dilek Tuzun, Ayten Oguz, Sedat Caner, Ali A. Tam, Neslhan Cuhaci, Reyhan Ersoy, Bekir Cakir | 5. Clinical case reports |
| P619 | OUR CLINICAL EXPERIENCE IN PERCUTENOUS ETHANOL INJECTION INTO CYSTIC TYROID NODULES | Bekir Cakir, Rifki Ucler, Dilek Arpaci, Fevzi Balkan, Ahmet Dirikoc, Reyhan Ersoy | 5. Clinical case reports |
| P620 | TWO CASES OF ALLERGIC REACTIONS WHICH HAS DEVELOPED DUE TO USAGE OF INSULIN ANALOGUES | Ayten Oguz, Serap Inancli, Gülfem Kaya, Burcak Polat, Ahmet Metin, Reyhan Ersoy, Bekir Cakir | 5. Clinical case reports |
| P621 | Sheehan's Syndrome Primary Presenting as Central Diabetes Insipidus: a Case Report | R Rangel, A Borges, A Afonso, A Agapito | 5. Clinical case reports |
| P622 | HEPATIC METASTASIS OF PARATHYROID CARCINOMA: CASE REPORT | F Fonseca, J Narciso, A Agapito, C Gasparinho, P Guerra, J Coutinho, C Gomes da Costa | 5. Clinical case reports |
| P623 | IGF-2 producing prostate tumour causing severe hypoglycaemia /case report/ | Gy Barta, J. Vadasz, G. Krasznai, A. Zalatnai, L. Fink | 5. Clinical case reports |
| P624 | 17β-HYDROXYSTEROID DEHYDROGENASE TYPE 3 DEFICIENCY: A NEW CASE OF A RARE DISEASE WITH AN UNCOMMON GENE MUTATION | M GALDIERO, P VITALE, F Cariati, L.F.S GRASSO, A COZZOLINO, C SIMEOLI, L Afeltra, C Piscopo, R Rossi, D Melis, C Alviggi, G Lombardi, A Colao, R Pivonello | 5. Clinical case reports |
| P625 | Testicular microlithisis – how worried should we be? | MJ Matos, P Freitas, D Carvalho | 5. Clinical case reports |
| P626 | VIRILIZING OVARIAN STEROID CELL TUMOR: CLINICAL CASE | MJ Matos, P Freitas, MA Costa, V Paiva, M Guimarães, JM Lopes, D Carvalho | 5. Clinical case reports |
| P627 | Clinical, hormonal and cytogenetic evaluation of 46,XX male. | M. Vetri, A. Stancampiano, L. Licciardello | 5. Clinical case reports |
| P628 | 5 year follow-up of recurrent parathyroid carcinoma in a young man: a case report | D Grigorie, M Ivan, M Ionescu, M Ghemigian, B Stanescu, D Ioachim, A Sucaliuc, A Diaconescu | 5. Clinical case reports |
| P629 | Unexpected Association: Turner Syndrome and Hypopituitarism – 2 case report | C Cucu, C Poiana, D Hortopan, A Dumitrascu, O Popa, S Gurau, R Danciulescu, M Musat | 5. Clinical case reports |
| P630 | A rare variant of Wolfram syndrome with diabetic microvascular disease, hypergonadotropic hypogonadism and palmar fibromatosis – case report | c preda, i gaspar, m-c ungureanu, l leustean, c cristea, l moisii, v mogos, c vulpoi | 5. Clinical case reports |
| P631 | “ UTERINE NEUROENDOCRINE TUMOUR –AN UNUSUAL CAUSE OF HYPONATRAEMIA” AND THE ROLE OF TOLVAPTAN, A VASOPRESSIN V2 RECEPTOR ANTAGONIST | G Mlawa, S Price, L Fraser, R Green, B Turner, R Guy | 5. Clinical case reports |
| P632 | Diagnosis of Bruns-Garland syndrome in a patient with McArdle disease and type 2 Diabetes Mellitus | Raquel Martins, Celestino Neves, Manuel Vaz-da-Silva, Pedro Rodrigues, Sandra Belo, Georgina Jorge, Ângela Magalhães, José Luís Castedo, Davide Carvalho | 5. Clinical case reports |
| P633 | Lower limb Merkel cell carcinoma with a single metastasis in a thyroid nodule | R. Martins, J. Couto, A.P. Santos, M. Ribeiro, L. Giesteira, A. Polinário, I. Torres | 5. Clinical case reports |
| P634 | An old story again with a new patient in modern world: acute adrenal insufficiency in a 51-year old man with vertebral tuberculosis | Inan Anaforoglu, Ekrem Algun, Omer Incecayir, Cigdem Siviloglu | 5. Clinical case reports |
| P635 | A case of a parathyroid adenoma with Celiac disease: primary or quaternary hyperparathyroidism? | Inan Anaforoglu, Ekrem Algun, Kerem Ersoy | 5. Clinical case reports |
| P636 | A case of congenital adrenal hyperplasia of 11 beta hydroxylase deficiency presented with Addisonian crisis | Ekrem Algun, Inan Anaforoglu, Omer Incecayir | 5. Clinical case reports |
| P637 | DIABETES AND A1C. HOW A HEMOGLOBIN VARIANT AFFECT A1C TEST. A CASE REPORT. | M Alves, M Bastos, M Ribeiro, J Santos, A Vieira, S Gouveia, J Saraiva, M Carvalheiro | 5. Clinical case reports |
| P638 | HYPONATREMIC COMA WITH SEIZURES AS ONSET OF ISOLATED ACTH DEFICIENCY | R.A. Trifanescu, A. Stoicescu, A. Caragheorgheopol, D. Hortopan, Mihail Coculescu | 5. Clinical case reports |
| P639 | Growth hormone in Prader-Willi syndrome – to treat or not to treat | C Vulpoi, C Rusu, D Boisteanu, I Vasiliu, J Idriceanu, R Balcan, I Potorac, V Mogos | 5. Clinical case reports |
| P640 | Subacute onset of severe Riedel thyroiditis associated with hypoparathyroidism and left recurrent palsy | Simona Verzea- Jercalau, Bogdan Stanescu, Corin Badiu | 5. Clinical case reports |
| P641 | Multiple pituitary deficiencies in a young patient with primary empty sella | A. Rusu, C. Cristea, L. Gheorghiu, R. Balcan, V. Mogos | 5. Clinical case reports |
| P642 | GIANT INVASIVE MACROPROLACTINOMA | M Alves, C Neves, J Pereira, M Ayres Bastos, I Bernardes, D Carvalho-Braga, D Carvalho | 5. Clinical case reports |
| P643 | BEXAROTENE ASSOCIATED DYSLIPIDAEMIA AND CENTRAL HYPOTHYROIDISM IN A PATIENT WITH SÉZARY SYNDROME | M Alves, C Neves, F Azevedo, O Correia, D Carvalho-Braga, D Carvalho | 5. Clinical case reports |
| P644 | DIFFUSE NODULAR HYPERPLASIA OF THE ADRENAL CORTEX IN A PATIENT WITH RENAL CYSTS | A. Michou, I. Kostoglou-Athanassiou, A. Chronaiou, S. Tagara, V. Trianti, A. Stefanaki, O. Karagianni, A. Karfi | 5. Clinical case reports |
| P645 | A CASE OF POLYMYOSITIS AND VASCULITIS INDUCED BY OVULATION INDUCTION THERAPY WITH GONADOTROPIN-RELEASING HORMONE (GnRH) – CASE REPORT. | J. Petrikova, J. Figurova, M. Švajdler, I. Lazurova | 5. Clinical case reports |
| P646 | DIABETES INSIPIDUS IN A PATIENT WITH BREAST CARCINOMA | J. Couto, A.P. Santos, R. Martins, L. Giesteira, I. Torres | 5. Clinical case reports |
| P647 | Ovarian hyperthecosis with type 2 diabetes mellitus and severe insulin resistance in postmenopausal woman | Vadim Gavan, Andra Caragheorgheopol, Adrian Vaduva, Crsitian Poalelungi, Radu Lichiardopol, Corin Badiu | 5. Clinical case reports |
| P648 | How differentiated can a poorly differentiated thyroid cancer be? A rare case presenting with hyperthyroidism and secondary adrenal insufficiency | M Melo, F Carrilho, C Ribeiro, M Carvalheiro | 5. Clinical case reports |
| P649 | HDR SYNDROME OR BARAKAT SYNDROME | D. Stefanopoulos, I. Kostoglou-Athanassiou, G. Vassiliou, K. Tzioras, A. Vryonidou, A. Karfi | 5. Clinical case reports |
| P650 | COINCIDENTAL PRESENCE OF ACROMEGALY AND NONCLASSICAL CONGENITAL ADRENAL HYPERPLASIA IN A PATIENT WITH HIRSUTISM; A CASE REPORT | Arzu Gedik, Mehmet Muhittin Yalcin, Abdurrahman Comlekci | 5. Clinical case reports |
| P651 | ADRENAL REST IN A PATIENT WITH LATE ONSET 21-HYDROXYLASE DEFICIENCY | A. Chronaiou, I. Kostoglou-Athanassiou, A. Michou, S. Kotanoglou, G. Vassiliou, K. Tzioras, V. Loi, A. Karfi | 5. Clinical case reports |
| P652 | Long term evolution of a coincident ACTH-dependent and independent Cushing’s syndrome | Claudia Nogueira, Eduardo Vinha, Josue Pereira, Ines Bernardes, Taveira Gomes, Joana Pardal, Herberto Bettencourt, Davide Carvalho | 5. Clinical case reports |
| P653 | MALTOSE INTERFERENCE IN THE DETERMINATION OF BLOOD GLUCOSE LEVELS BY TEST STRIPS BASED ON GLUCOSE DEHYDROGENASE-PQQ METHOD - A CASE REPORT | S. Belo, P. Rodrigues, M. Alves, C. Neves, A. Magalhães, D. Carvalho | 5. Clinical case reports |
| P654 | TYPE II POLYGLANDULAR SYNDROME – A CASE REPORT | S. Belo, A. Magalhães, D. Carvalho | 5. Clinical case reports |
| P655 | Impact of two novel mutations of calcium sensing receptor (CaSR) gene on calcium metabolism: two clinical case reports. | Elena Livadariu, Renata Simona Auriemma, Catherine Rydlewski, Silvia Vandeva, Anne Sophie Thonnard, Daniela Betea, Adrian F Daly, Albert Beckers | 5. Clinical case reports |
| P656 | Comparative levels of Serum/Plasma concentrations of hormones in Juvenile periodontitis patients of Pakistan. | Ayesha Anwar, Hamid Qureshi | 6. Developmental endocrinology |
| P657 | Zilpaterol hydrochloride (a β-agonist) improves growth performance and carcass quality in castrated goat | A Towhidi, A Hatefi, S Zeinoaldini, A Zali, M Ganjkhanlou | 6. Developmental endocrinology |
| P658 | Disorders of sex development - current scenario in North East India | UK Saikia, SD Choudhury | 6. Developmental endocrinology |
| P659 | Cost-effectiveness analysis of conservative treatment strategy in patients with diabetic foot in Moscow | Nadezhda Maximova, Marina Kalashnikova | 6. Developmental endocrinology |
| P660 | METHOD OF MYOCARDIAL PRECONDITIONING DURING EXERCISE TESTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AFTER ACUTE MYOCARDIAL INFARCTION | Tatiana Chernyavskaya, Ekaterina Meskhidze, Igor Boravkov | 7. Diabetes therapy |
| P661 | Effect of amino acid residues on N-terminal extension of GLP-1/IgG-Fc fusion protein | C. Lee, J. Boyineni, H.-S. Chung, S.-H. Jang | 7. Diabetes therapy |
| P662 | Evaluation of the global impact of incorporating a telemedicine system for type 1 diabetes patients with an insulin pump and real-time continuous glucose monitoring system. | I Gonzalez-Molero, M Domínguez-López, M Guerrero, M Carreira, F Caballero, M Anarte, MS Ruiz de Adana, F Soriguer | 7. Diabetes therapy |
| P663 | Evaluation of adolescents type 1 diabetic patients after transition from paediatric to adult care | M Domínguez-López, I González-Molero, S RuizdeAdana-Navas, A delPino, JP López, JD Fernández, G Olveira, F Soriguer | 7. Diabetes therapy |
| P664 | Clinical effectiveness of a Bolus Calculator in patients with type 1Diabetes Mellitus treated with insulin pump | M Domínguez-López, I González-Molero, M RuizdeAdana, M Guerrero, I Cardona, N Colomo, F Soriguer | 7. Diabetes therapy |
| P665 | EVALUATION OF LONG TERM OUTCOMES OF INTENSIVE TREATMENT WITH SUBCUTANEOUS INSULIN INFUSION (CSII) IN TYPE 1 DIABETIC PATIENTS | I González-Molero, M Domínguez-López, E Rubio, M Carreira, MS Ruiz de Adana, S González-Romero, A Machado, F Soriguer | 7. Diabetes therapy |
| P666 | EXPERIENCE WITH THE USE OF A REAL TIME CONTINUOUS GLUCOSE MONITORING SYSTEM DURING THE SIMULTANEOUS PANCREAS KIDNEY TRANSPLANT | I González-Molero, M Domínguez-López, MS Ruiz de Adana, S González-Romero, M Gonzalo-Marín, S Valdes, G Olveira, F Soriguer | 7. Diabetes therapy |
| P667 | Unacylated ghrelin improves insulin sensitivity in the early phase of obesity | PJD Delhanty, M Huisman, I van den Berge, T Abribat, APN Themmen, AJ van der Lely | 7. Diabetes therapy |
| P668 | Antihyperglycemic action of creatine compared to glibenclamide in type II diabetic patients | M Vucic Lovrencic, A Znaor, T Poljicanin, P Rocic, DS Weber, B Rocic | 7. Diabetes therapy |
| P669 | Impact of a DPP4-inhibitor on liver and heart lipid content and cardiovascular risc in type 2 diabetic patients | L Kosi, M Chmelik, S Trattnig, A Luger, A Kautzky-Willer | 7. Diabetes therapy |
| P670 | SELF-MONITORING OF BLOOD GLUCOSE IN TYPE 2 DIABETES MELLITUS: EFFECT ON GLYCEMIC CONTROL IN NON-INSULIN-TREATED PATIENTS | B Madeo, S Scaltriti, S Romano, C Diazzi, M El Goch, A R M Granata, E R Cavani, C Carani, V Rochira | 7. Diabetes therapy |
| P671 | Insulin resistance of multiple metabolic pathways in patients with type 1 diabetes on long term continuous subcutaneous insulin infusion therapy | E. Donga, M. van Dijk, R.P.L.M. Hoogma, E.P.M. Corssmit, J.A. Romijn | 7. Diabetes therapy |
| P672 | Factors related with the adherence of physicians to diabetes guidelines in type 2 DM patients in Turkey | I Satman, S Imamoglu, C Yilmaz, ADMIRE Study Group | 7. Diabetes therapy |
| P673 | Effects of Estradiol + Drospirenone on Sexual Function in Postmenopausal Women with Type 2 Diabetes Mellitus | AS Pogorelova, TU Berketova, AK Ragozin | 7. Diabetes therapy |
| P674 | Effect of Sitagliptin Monotherapy on Serum Total Ghrelin Levels in Type 2 Diabetic Patients | O Oz Gul, S Kiyici, C Ersoy, S Cander, O.K Unal, E Erturk, E Tuncel, S Imamoglu | 7. Diabetes therapy |
| P675 | UK National Exenatide Guidelines (NICE:CG87) compared to clinical outcomes at a district general hospital's diabetes department. | D Hughes, H Butterworth, R Mahto | 7. Diabetes therapy |
| P677 | Comparative study of combination therapy between metformin plus thiazolinedione(TZD) and metformin plus DPP-4 inhibitor in Type 2 diabetes. | Yonghyun Kim, Donghyun Shin, Eunjong Lee | 7. Diabetes therapy |
| P678 | Insulin Analogue Management– subjective and objective assessment of life quality in patients previously managed with human insulin | Zoran Gluvic, Zorica Rasic-Milutinovic, Jelena Tica, Milena Lackovic, Marina Vujovic, Vesna Popovic-Radinovic, Esma Isenovic-Milivojevic, Jelena Jankovic | 7. Diabetes therapy |
| P679 | 12 MONTHS EXENATIDE TREAMENT IN TYPE 2 DIABETES AND SEVERE OBESITY | M Diéguez Felechosa, C Tusón Rovira, C Sánchez Ragnarsson, E Suárez-LLedo Alemany, L Cacho Garcia, N Valdes Gallego, J Prieto Santiago | 7. Diabetes therapy |
| P680 | New opportunity of treatment women with postmenopausal osteoporosis and diabetes mellitus type 2. | Elena Doskina, Irina Kochergina, Alexander Ametov | 7. Diabetes therapy |
| P681 | Effects of lifestyle changes on incidents of type II diabetes in Tehran adult population | laleh ghanei, fereidoun azizi, farzad hadaegh | 7. Diabetes therapy |
| P682 | The addition of acipimox in patients with type 2 diabetes with triglyceride level over 150 mg/dL in spite of fenofibrate therapy | D-M Kim, JR Park | 7. Diabetes therapy |
| P683 | MONITORING THYROID FUNCTION IN DIABETIC PATIENTS ON TREATMENT WITH GLUCAGON-LIKE PEPTIDE 1 ANALOG | R Danciulescu, M Musat, R Rosca, V Cristescu, C Poiana | 7. Diabetes therapy |
| P684 | Impact of Structured Testing on Level of Glycemic Control | SPP Popovic-Pejicic, VK Karlovic | 7. Diabetes therapy |
| P685 | INSULIN THERAPY OF DIABETES MELLITUS TYPE 2 AND RISK OF DEVELOPMENT CARDIOVASCULAR MORTALITY | Alexander Ametov, Irina Kochergina, Elena Doskina, Kermen Ulanova | 7. Diabetes therapy |
| P686 | Diabetic Retinopathy in Type 1 Diabetes Mellitus Patients with Depression | Yana Navmenova, Tatiana Mokhort, Marina Kaplieva | 8. Diabetes complications |
| P687 | The frequency distribution of PPARγ2 Pro12Ala polymorphism in type 2 diabetic, cardiac patients and healthy subjects of Bangladeshi population | Abdullah Emran, Abul kalam Azad Chowdhury, Colin Palmer | 8. Diabetes complications |
| P688 | THE RISK FACTORS FOR CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES PATIENTS | V Mladenovic, A Djukic, J Petrovic, S Sipetic | 8. Diabetes complications |
| P689 | STUDY OF ENDOTHELIAL DYSFUNCTION IN DIABETES. ASSESMENT OF ANP LEVES IN PATIENTS WITHOUT VASCULAR DISEASE. | MARIA ROSA VILLAR VICENTE, NOEMI GONZALEZ PEREZ DE VILLAR, CARMEN ALAMEDA HERNANDO, ANTONIO BECERRA FERNANDEZ | 8. Diabetes complications |
| P690 | Obese diabetics and left ventricular hypertrophy. | Ergita Nelaj, Margarita Gjata, Ledio Collaku, Mihal Tase | 8. Diabetes complications |
| P691 | Psychoemotional Status and Quality of Life of T1DM Patients | Maria Rusalenko, Tatiana Mokhort, Aleksander Rozhko, Tamara Sharshakova, Irina Davydova, Yana Navmenova | 8. Diabetes complications |
| P692 | FEATURES OF THE LIPID EXCHANGE AMONG THE PATIENTS SUFFERING FROM DIABETES WITH VARIOUS DEGREE OF CARBOHYDRATE EXCHANGE COMPENSATION | Irina Savasteeva, Olga Chernysh | 8. Diabetes complications |
| P693 | Diabetic foot with risk for ulceration associated with diabetic retinopathy in type 2 diabetes | I Ahmeti, N Laban - Guceva, B. Jovanovska, T Milenkovic, K Adamova | 8. Diabetes complications |
| P694 | Type 2 diabetes mellitus and testosterone: a meta-analysis study. | Giovanni Corona, Matteo Monami, Giulia Rastrelli, Antonio Aversa, Andrea Lenzi, Gianni Forti, Edordo Mannucci, Mario Maggi | 8. Diabetes complications |
| P695 | Early Diagnostics of Diabetic Peripheral Neuropathy Manifestations in Patients with Diabetes Mellitus | Elena Vaschenko, Irina Savasteeva, Heorhi Ramanau | 8. Diabetes complications |
| P696 | Changes in GLUT1 expression under metformin treatment in rat models of severe and mild stretozotocin diabetes mellitus | Jelizaveta Sokolovska, Sergejs Isajevs, Olga Sugoka, Jelena Sharipova, Lasma Lauberte, Darja Svirina, Evita Rostoka, Tatjana Sjakste, Ivars Kalvinsh, Nikolajs Sjakste | 8. Diabetes complications |
| P697 | The study of DM late complications prevalence and risk factors contributing to their progression in urban and rural diabetics of Uzbekistan | Saidganihodja Ismailov, Nilufar Ibragimova, Dilfuza Berdykulova | 8. Diabetes complications |
| P698 | Illuminating diabetic neuropathy - novel systems for in vivo monitoring and microenvironmental investigations in a murine model. | S Amit, A Yaron | 8. Diabetes complications |
| P699 | Gilbert Syndrome and Diabetes – a perfect union? | MJ Matos, SB Souto, AI Oliveira, S Silva, E Vinha, P Freitas, J Queirós, DC Braga, D Carvalho | 8. Diabetes complications |
| P700 | Influence of metabolic disorders in children with Diabetes Mellitus type 1 on changes of QT interval. | Galina Meraai, Angelika Solntseva | 8. Diabetes complications |
| P701 | Receptor Activator of Nuclear Factor Kappa β Ligand and Osteoprotegerin Levels in the Patients with Diabetic Nephropathy | Cigdem Kuzuguden, Sibel Guldiken, Sedat Ustundag, Zeren Ozgen, Muzaffer Demir | 8. Diabetes complications |
| P702 | Matrix γ-carboxyglutamate (Gla) protein (MGP) in type 2 diabetes | M.I. Belovici, M. Buysschaert | 8. Diabetes complications |
| P703 | DIABETIC PATIENTS WITH AUTONOMIC NEUROPATHY DO NEED ERYTHROPOETIN THERAPY AT THE EARLY STAGIES OF RENAL FAILURE | S Giannakaki, E Chrysanthopoulou, A Georgiou, G Fioretos, E Linardoutsou, G Papadakis | 8. Diabetes complications |
| P704 | Beta estrogen receptors inhibition improves wound healing in diabetes | I.R Botusan, V. G. Sunkari, J. Grunler, S. Lindberg, O. Savu, K Steffensen, K Brismar, S.B Catrina | 8. Diabetes complications |
| P705 | Diabetes mellitus and risk of fracture | A.A. Gusova, M.G. Pavlova, G.A. Melnichenko, G.M. Kavalersky, L.L. Silin, Yu.I. Sountsov | 8. Diabetes complications |
| P706 | Health illiteracy as a challenge in contemporary endocrinology | K Marczewski, M Rebisz, J Wrobel | 8. Diabetes complications |
| P707 | Adrenocortical hypofunction in patients with diabetes mellitus type 1 | K Simunkova, K Vondra, M Hill, M Duskova, L Kriz, L Starka | 8. Diabetes complications |
| P708 | Effect of Oxytocin on the Blood Glucose Level in Rat | Y Dezhkam, EP López-Damián, N Dezhkam, S Nafisi | 8. Diabetes complications |
| P709 | Cytochemical analysis of glycogen in mucous cells as noninvasive diagnostic technique of type 2 diabetes mellitus | Rudolf Yuy Tsun-Shu, Alma Mansharipova, Sholpan Mulkibayeva | 9. Diabetes (to include epidemiology, pathophysiology) |
| P710 | Continuous glucose monitoring enhances the diagnostic value of mixed meal test in reactive hypoglycemia | Ilaria Olivetti, Giorgio Grassi, Veronica Lambertenghi, Michela Tomelini, Valentina Ramella Gigliardi, Elena Gramaglia, Ezio Ghigo, Fabio Broglio | 9. Diabetes (to include epidemiology, pathophysiology) |
| P711 | VITAMIN D AND GESTATIONAL DIABETES | J. PI, IF. VALLINA, F. ALONSO, I. PEÑUELA, B. CATÓN, E. TUTOR, E. SANTOS | 9. Diabetes (to include epidemiology, pathophysiology) |
| P712 | The frequency of Cushing’s disease among obes, type 2 diabetes mellitus patients: A single center experience in Turkey | Ozcan Karaman, Sayid Shafi Zuhur, Esra Cil, Aysenur Ozderya, Feyza Yener Ozturk, Yuksel Altuntas | 9. Diabetes (to include epidemiology, pathophysiology) |
| P713 | RESTING ENERGY EXPENDITURE IN IMPAIRED GLUCOSE METABOLISM | Betül Ekiz Bilir, Neslihan Soysal Atile, Bülent Bilir, Sibel Güldiken | 9. Diabetes (to include epidemiology, pathophysiology) |
| P714 | A rare case: Shwachman-Diamond syndrome presenting with diabetic ketoacidosis | M. Fatih Akdogan, Mustafa Altay, Nazim Denizli, Murat Gucun, Seher Tanrikulu, Murat Duranay | 9. Diabetes (to include epidemiology, pathophysiology) |
| P715 | Autoimmune markers in patients with type 1 diabetes mellitus | Didem Ozdemir, Husniye Baser, Rifki Ucler, Alper Usluogullari, Reyhan Ersoy, Bekir Cakir | 9. Diabetes (to include epidemiology, pathophysiology) |
| P716 | Prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes | M Boyanov, J Boneva, D Bakalov, G Sheinkova, G Prodanova | 9. Diabetes (to include epidemiology, pathophysiology) |
| P717 | The fed to fasting transition differentially affects PEPCK protein expression in pericentral and periportal murine hepatocytes | H. Herrema, J.F,W. Baller, F. Kuipers, A.K. Groen, A. Grefhorst | 9. Diabetes (to include epidemiology, pathophysiology) |
| P718 | Disturbed subjective sleep characteristics in adult patients with type 1 diabetes mellitus | M van Dijk, E Donga, JG van Dijk, GJ Lammers, KW van Kralingen, OM Dekkers, EPM Corssmit, JA Romijn | 9. Diabetes (to include epidemiology, pathophysiology) |
| P719 | PREVALENCE OF DEPRESSIVE SYNDROME IN TYPE 2 DIABETES. SOCIODEMOGRAPHIC, CLINICAL AND BIOCHEMICAL DIFFERENCES | Joana Nicolau Ramis, Rosmeri Rivera Irigoin, Carla Francés Artigas, Josefina Olivares Alcolea, Irene Rodríguez Rodríguez, Luis Alberto Gómez Gómez, Apolonia Gil Palmer, Lluís Masmiquel Comas | 9. Diabetes (to include epidemiology, pathophysiology) |
| P720 | Diagnostic Criteria for Glucose Homeostasis Abnormalities in Obese Patients: Are There Any Differences? | J Mesquita, P Rodrigues, C Nogueira, S Belo, C Esteves, MJ Matos, A Varela, P Freitas, Joana Queirós, Flora Correia, Bruno Oliveira, Manuel Ferreira de Almeida, João Tiago Guimarães, José Luís Medina, Davide Carvalho | 9. Diabetes (to include epidemiology, pathophysiology) |
| P721 | GLYCATED HEMOGLOBIN AS DIAGNOSTIC CRITERIA FOR DIABETES AND PREDIABETES IN OBESE PATIENTS | A Lopes, J Silva-Nunes, C Santos, C Godinho, I Rodrigues, A Agapito | 9. Diabetes (to include epidemiology, pathophysiology) |
| P722 | Impact of INSR His1085 and IRS1 Gly972Arg Genetic Variability on Dyslipidaemia in Patients with Metabolic Syndrome and Type 2 Diabetes | D Katalinic, N Nikolac, V Zjacic-Rotkvic, M Solter, E Topic, M Vrkljan, S Plestina | 9. Diabetes (to include epidemiology, pathophysiology) |
| P723 | High prevalence of impaired glucose metabolism in young adult patients with Williams Syndrome. | B Masserini, MF Bedeschi, V Bianchi, ME Lunati, F Lalatta, P Beck-Peccoz, E Orsi | 9. Diabetes (to include epidemiology, pathophysiology) |
| P724 | TCF7L2 gene variants and plasma C-peptide concentrations in Diabetes type 2. | MC Ferreira, MCA Marques, RT Fukui, MR Correia, MER Silva, DM Rocha, RF Santos | 9. Diabetes (to include epidemiology, pathophysiology) |
| P725 | "Risk factors of conversion from IGT and IFG to diabetes type 2 | BPS Piwonska-Solska, DP Pach, AGJ Gilis-Januszewska, AHD Hubalewska-Dydejczyk | 9. Diabetes (to include epidemiology, pathophysiology) |
| P726 | Effects of the ghrelin gene products on glucose metabolism in C2C12 muscle cells | Cristina Grande, Fabio Settanni, Iacopo Gesmundo, Marina Taliano, Ezio Ghigo, Riccarda Granata | 9. Diabetes (to include epidemiology, pathophysiology) |
| P727 | Effects of Ramadan fasting on Resting Energy Expenditure in T2DM | mohsen Khoshniat, Sassan Sharghi | 9. Diabetes (to include epidemiology, pathophysiology) |
| P728 | Chronic supplementation of beta-hydroxy-beta methylbutyrate (HMβ) impairs glucose homeostasis in rats under normal conditions | F.G-R. Gerlinger-Romero, C.Y.Y Yogi Yonamine, R.S.C. Saldanha Campello, L.G-F. Guimarães-Ferreira, U.F.M. Fabres Machado, M.T.N. Tereza Nunes | 9. Diabetes (to include epidemiology, pathophysiology) |
| P729 | Serum Levels of Fetuin-A Correlate with Bone Turnover Biomarkers in Patients with Type 2 Diabetes Mellitus | Sazan Rasul, Jelena Todoric, Aysegül Ilhan, Harald Esterbauer, Alexandra Kautzky-Willer | 9. Diabetes (to include epidemiology, pathophysiology) |
| P730 | The sress influence on the diabetes mellitus occurrence in the territory of northern Kosovo and Metohija in the period 2000-2002. | Slavica Pajovic | 9. Diabetes (to include epidemiology, pathophysiology) |
| P731 | Prevalence of a gestational diabetes and it`s risk factors estimation. | Ekaterina N. Giniyatullina, Hyady M. Torshkhoeva, Rosa M. Esayan, Oksana I. Kolegaeva, Olga N. Tkacheva | 9. Diabetes (to include epidemiology, pathophysiology) |
| P732 | RELATIONSHIP BETWEEN DIABETES AND PANCREATIC CANCER | M Alves, M Bastos, J Santos, A Vieira, S Gouveia, J Saraiva, M Carvalheiro | 9. Diabetes (to include epidemiology, pathophysiology) |
| P733 | Vaspin circulating levels in severely obese women with type 2 diabetes mellitus (T2DM): early changes following restrictive bariatric surgery. | I Kyrou, M Fried, P Sramkova, K Dolezalova, O Bradnova, V Hainer, P McTernan, S Kumar, Jana Vrbikova | 9. Diabetes (to include epidemiology, pathophysiology) |
| P734 | Does anxiety influence food preference and insulin resistance in healthy men? | Ludmila Brunerova, Jana Potockova, Jiri Horacek, Michal Andel | 9. Diabetes (to include epidemiology, pathophysiology) |
| P735 | Insulin restores salivary secretion in diabetic rats: involvement of Na+/glucose cotransporter SGLT1 | R Sabino-Silva, RS Campello, HK Nakamura, HS Freitas, MM Okamoto, RC Mori, UF Machado | 9. Diabetes (to include epidemiology, pathophysiology) |
| P736 | The Prevalence of Diabetes Mellitus In HIV Infected Patients On Treatment With Antiretoviral Drugs | R Danciulescu, M Musat, V Cristescu, C Poiana | 9. Diabetes (to include epidemiology, pathophysiology) |
| P737 | Linking CERN and TERM – testing the acceleration hypothesis. | S Dautovic, R Dautovic | 9. Diabetes (to include epidemiology, pathophysiology) |
| P738 | Metabolic Syndrome in Normotensive Non Diabetic population in Jeddah- a pilot study | S Bahijri, D Akbar, R Al Raddadi | 9. Diabetes (to include epidemiology, pathophysiology) |
| P739 | COST OF TREATING DIABETES IN A DEVELOPING ECONOMY | BA Kolawole, AA Olugbodi | 9. Diabetes (to include epidemiology, pathophysiology) |
| P740 | Comparison of the diagnostic criteria for PreDiabetes on an overweight population | Mafalda Marcelino, Paula Chambel, Manuel Paradinha, Andreia Domingues, Dolores Passos, Luis Lopes, Maria Lopes, João Castro | 9. Diabetes (to include epidemiology, pathophysiology) |